###begin article-title 0
Rad9 plays an important role in DNA mismatch repair through physical interaction with MLH1
###end article-title 0
###begin p 1
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 1
###begin p 2
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 565 566 565 566 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 23 28 <span type="species:ncbi:4932">yeast</span>
###xml 32 38 <span type="species:ncbi:9606">humans</span>
###xml 307 312 <span type="species:ncbi:9606">human</span>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
Rad9 is conserved from yeast to humans and plays roles in DNA repair (homologous recombination repair, and base-pair excision repair) and cell cycle checkpoint controls. It has not previously been reported whether Rad9 is involved in DNA mismatch repair (MMR). In this study, we have demonstrated that both human and mouse Rad9 interacts physically with the MMR protein MLH1. Disruption of the interaction by a single-point mutation in Rad9 leads to significantly reduced MMR activity. This disruption does not affect S/M checkpoint control and the first round of G2/M checkpoint control, nor does it alter cell sensitivity to UV light, gamma rays or hydroxyurea. Our data indicate that Rad9 is an important factor in MMR and carries out its MMR function specifically through interaction with MLH1.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 445 446 445 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 574 575 574 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 576 577 576 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 706 707 706 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 708 709 708 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 710 711 710 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 846 850 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6 B7 B8 B9 B10 B11">6&#8211;11</xref>
###xml 933 958 933 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schizosaccharomyces pombe</italic>
###xml 989 990 989 990 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1132 1137 1128 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12 B13 B14 B15">12&#8211;15</xref>
###xml 1282 1284 1274 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1285 1287 1277 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 919 932 <span type="species:ncbi:4896">fission yeast</span>
###xml 933 958 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 1029 1042 <span type="species:ncbi:4896">fission yeast</span>
###xml 1158 1163 <span type="species:ncbi:10090">mouse</span>
###xml 1205 1210 <span type="species:ncbi:10090">mouse</span>
Errors and damage of genomic DNA occur during normal cellular activities or when cells are exposed to genotoxins. Cells manage DNA errors and damage using an intricate network consisting of many proteins including cell cycle checkpoint proteins and DNA repair factors. The main DNA repair mechanisms include homologous recombination (HR), nonhomologous end-joining, base excision, nucleotide excision, direct reversal and mismatch repair (MMR) (1,2). When DNA is damaged, the progress of cells through the cell cycle is arrested or slowed down to allow time for DNA repair (2,3). Cell cycle checkpoint proteins Rad9, Rad1 and Hus1 play important roles in both cell cycle checkpoint control and DNA repair (2,4,5). These three proteins are evolutionarily conserved in eukaryotes, and can form a ring-shaped heterotrimer, dubbed the 9-1-1 complex (6-11). The deletion of each of the three genes for these proteins in the fission yeast Schizosaccharomyces pombe inactivates S/M, intra-S and G2/M checkpoint controls, and sensitizes fission yeast cells to killing by UV light, gamma-rays and the replication inhibitor hydroxyurea (HU) (12-15). Disruption of the mouse ortholog of Rad9 or Hus1 also sensitizes mouse cells to UV light, gamma-rays and HU, and leads to genome instability (16,17).
###end p 5
###begin p 6
###xml 297 302 297 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18 B19 B20 B21">18&#8211;21</xref>
###xml 305 313 305 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 484 489 484 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22 B23 B24">22&#8211;24</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 770 772 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 984 986 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1095 1102 1095 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
MMR is an important repair mechanism that maintains genomic stability. It plays key roles in the repair of base-base mismatches and insertion/deletion mispairs generated during DNA replication and recombination. MMR also functions in preventing HR and in DNA damage signaling in eukaryotic cells (18-21). In vitro reconstitution biochemical studies indicate that MutS, MutL, RPA, EXOI, HMGB1, PCNA, replication factor C (RFC), polymerase and DNA ligase I play important roles in MMR (22-24). EXOI is only partially responsible for excision enzyme activity in MMR (25,26). A recent study showed that regulatory factor X has a stimulatory role in mismatch-dependent 5' to 3' excision activity (27). hMRE11 was found to play a role in mismatch-dependent 3' to 5' excision (28). Furthermore, the excision of reconstituted MMR proteins is less specific than in cell extracts, suggesting that one or more additional regulatory factors are required for the accuracy of the excision step (22,29). Therefore, other protein components are required for MMR to work efficiently and accurately under various in vivo conditions.
###end p 6
###begin p 7
###xml 342 343 342 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
In this study, Rad9 was found to physically interact with mammalian MLH1, a protein essential for DNA MMR. A single amino acid residue mutation (S160A) on Rad9 drastically weakened its interaction with MLH1 and cellular mismatch repair activity. The mutation did not affect cell sensitivity to UV light, gamma rays or HU, and neither S/M or G2/M checkpoint controls, the typical phenotypes of Rad9-deleted cells (17), suggesting that Rad9 functions in MMR specifically through its interaction with MLH1.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
Antibodies
###end title 9
###begin p 10
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Anti-hRad9 polyclonal antibody was obtained by immunizing mice with purified MBP-hRad9 protein. Anti-hMLH1 monoclonal antibody (554 073) was from BD Biosciences Pharmingen, monoclonal anti-His antibody, monoclonal anti-FLAG M2 antibody (F1804), polyclonal anti-FLAG antibody (F7425) and anti-gamma-tubulin monoclonal antibody were obtained from Sigma-Aldrich, and anti-HA antibody was obtained from Santa Cruz Technology.
###end p 10
###begin title 11
Cell culture
###end title 11
###begin p 12
###xml 325 330 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 97 103 <span type="species:ncbi:9913">bovine</span>
Human HeLa and HEK 293T cells were cultured in DMEM (Invitrogen, CA) supplemented with 10% fetal bovine serum (Hyclone) and 100 U/ml penicillin/streptomycin. The 293T cells stably expressing FLAG-hRad9 constructed in our laboratory were cultured in DMEM with 10% FBS and 50 mug/ml Hygromycin B to keep the plasmid pFLAG-CMV2-hRad9 in the cells.
###end p 12
###begin p 13
Methyl methanesulfonate (MMS) and N-nitroso-N-methylurea (MNU), the alkylation agents for cell treatments were purchased from Sigma-Aldrich (St. Louis, MO). After HeLa cells reached 80% confluence and were rinsed twice with PBS, the cells were incubated with designated concentrations of MMS or MNU for 60 min in serum-free DMEM and cells were then harvested to prepare lysate for Western blot and co-immunoprecipitation analysis.
###end p 13
###begin p 14
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
Culture of mouse ES cells was described previously (17). The antibiotic zeocin, at a final concentration of 100 mug/ml, was added to cell cultures to select stable transfectants. The selected stable transfectants were cultured in medium containing 25 mug/ml zeocin to maintain the transfected genes in the cells.
###end p 14
###begin title 15
Mass spectrometry
###end title 15
###begin p 16
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
FLAG-hRad9 was immmunopurified from 1 x 108 293 T cells stably expressing FLAG-hRad9 using 200 mul anti-FLAG M2 agarose (Sigma). After extensive washings with lysis buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.5, 10% glycerol, 0.5% NP-40) containing a protease inhibitor cocktail (Roche, Indianapolis, IN), the bound proteins were eluted with 200 mug/ml FLAG peptide (Sigma) in PBS. Eluted proteins were resolved by SDS-PAGE and revealed by Coomassie blue staining or silver staining. The apparent bands were excised, in-gel digested with trypsin, and analyzed by LC-MS/MS on a ProteomeX-LTQ mass spectrometer (Thermo Fisher Scientific, Waltham, USA) to identify the protein bands.
###end p 16
###begin title 17
Co-immunoprecipitation
###end title 17
###begin p 18
###xml 25 27 25 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 258 263 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 420 427 420 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 433 438 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 666 674 666 674 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1.</label>
###xml 674 728 674 728 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="19">Primers used to amplify cDNA for constructing plasmids</p>
###xml 674 728 674 728 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="19">Primers used to amplify cDNA for constructing plasmids</p></caption>
###xml 728 736 728 736 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Plasmids</th>
###xml 736 742 736 742 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Primer</th>
###xml 742 759 742 759 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Restriction sites</th>
###xml 728 759 728 759 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Plasmids</th><th rowspan="1" colspan="1">Primer</th><th rowspan="1" colspan="1">Restriction sites</th></tr>
###xml 728 759 728 759 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Plasmids</th><th rowspan="1" colspan="1">Primer</th><th rowspan="1" colspan="1">Restriction sites</th></tr></thead>
###xml 770 775 770 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 759 775 759 775 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pFLAG-CMV2-<italic>hMLH1</italic></td>
###xml 775 814 775 814 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCATCGTTCGTGGCAGGGGTTAT-3&#8242;</td>
###xml 814 819 814 819 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">EcoRI</td>
###xml 759 819 759 819 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pFLAG-CMV2-<italic>hMLH1</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCATCGTTCGTGGCAGGGGTTAT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr>
###xml 819 819 819 819 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 819 857 819 857 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATACGCGGATCCTTAACACCTCTCAAAGACTT-3&#8242;</td>
###xml 857 862 857 862 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">BamHI</td>
###xml 819 862 819 862 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-ATACGCGGATCCTTAACACCTCTCAAAGACTT-3&#8242;</td><td rowspan="1" colspan="1">BamHI</td></tr>
###xml 873 878 873 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 862 878 862 878 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pCDNA3-6HA-<italic>hMLH1</italic></td>
###xml 878 913 878 913 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCTCGTTCGTGGCAGGGGT-3&#8242;</td>
###xml 913 918 913 918 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">EcoRI</td>
###xml 862 918 862 918 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pCDNA3-6HA-<italic>hMLH1</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCTCGTTCGTGGCAGGGGT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr>
###xml 918 918 918 918 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 918 954 918 954 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCTTAACACCTCTCAAAGAC-3&#8242;</td>
###xml 954 959 954 959 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">EcoRI</td>
###xml 918 959 918 959 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCTTAACACCTCTCAAAGAC-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr>
###xml 970 975 970 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 959 975 959 975 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pCDNA3-6HA-<italic>hRad9</italic></td>
###xml 975 1013 975 1013 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGAAGTGCCTGGTCACGGGCGG-3&#8242;</td>
###xml 1013 1017 1013 1017 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">XhoI</td>
###xml 959 1017 959 1017 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pCDNA3-6HA-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGAAGTGCCTGGTCACGGGCGG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr>
###xml 1017 1024 1017 1024 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(1-270)</td>
###xml 1024 1064 1024 1064 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;GCGCGCGGATCCCTACGAGTCGGTGTCTGAGAGTG-3&#8242;</td>
###xml 1064 1068 1064 1068 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">XhoI</td>
###xml 1017 1068 1017 1068 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">(1-270)</td><td rowspan="1" colspan="1">5&#8242;GCGCGCGGATCCCTACGAGTCGGTGTCTGAGAGTG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr>
###xml 1079 1084 1079 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 1068 1084 1068 1084 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pCDNA3-6HA-<italic>hRad9</italic></td>
###xml 1084 1122 1084 1122 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATACCCGAATTCCACTCCCAGGACCTGGGCTC-3&#8242;</td>
###xml 1122 1127 1122 1127 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">EcoRI</td>
###xml 1068 1127 1068 1127 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pCDNA3-6HA-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCGAATTCCACTCCCAGGACCTGGGCTC-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr>
###xml 1127 1136 1127 1136 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(271-391)</td>
###xml 1136 1174 1136 1174 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GCGCGCGGATCCTCAGCCTTCACCCTCACTGT-3&#8242;</td>
###xml 1174 1179 1174 1179 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">EcoRI</td>
###xml 1127 1179 1127 1179 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">(271-391)</td><td rowspan="1" colspan="1">5&#8242;-GCGCGCGGATCCTCAGCCTTCACCCTCACTGT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr>
###xml 1189 1194 1189 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 1179 1194 1179 1194 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td>
###xml 1194 1232 1194 1232 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGAAGTGCCTGGTCACGGGCGG-3&#8242;</td>
###xml 1232 1236 1232 1236 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">XhoI</td>
###xml 1179 1236 1179 1236 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGAAGTGCCTGGTCACGGGCGG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr>
###xml 1236 1243 1236 1243 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(1-130)</td>
###xml 1243 1281 1243 1281 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTCACAGTCCTGGAAGGACA-3&#8242;</td>
###xml 1281 1285 1281 1285 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">XhoI</td>
###xml 1236 1285 1236 1285 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">(1-130)</td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTCACAGTCCTGGAAGGACA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr>
###xml 1295 1300 1295 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 1285 1300 1285 1300 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td>
###xml 1300 1338 1300 1338 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGTCCCTGCAGGCCGTCTTCGA-3&#8242;</td>
###xml 1338 1342 1338 1342 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">XhoI</td>
###xml 1285 1342 1285 1342 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGTCCCTGCAGGCCGTCTTCGA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr>
###xml 1342 1351 1342 1351 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(131-270)</td>
###xml 1351 1392 1351 1392 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTAGTGCGAGTCGGTGTCTGAGA-3&#8242;</td>
###xml 1392 1396 1392 1396 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">XhoI</td>
###xml 1342 1396 1342 1396 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">(131-270)</td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTAGTGCGAGTCGGTGTCTGAGA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr>
###xml 1406 1411 1406 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 1396 1411 1396 1411 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td>
###xml 1411 1442 1411 1442 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATTCGGCTCGAGCCTGCACTGGCTG-3&#8242;</td>
###xml 1442 1446 1442 1446 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">XhoI</td>
###xml 1396 1446 1396 1446 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATTCGGCTCGAGCCTGCACTGGCTG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr>
###xml 1446 1455 1446 1455 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">(161-270)</td>
###xml 1455 1496 1455 1496 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTAGTGCGAGTCGGTGTCTGAGA-3&#8242;</td>
###xml 1496 1500 1496 1500 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">XhoI</td>
###xml 1446 1500 1446 1500 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">(161-270)</td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTAGTGCGAGTCGGTGTCTGAGA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr>
###xml 1500 1508 1500 1508 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">R9160A-F</td>
###xml 1508 1545 1508 1545 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-GCTGTTCTGCCCTTCGCTCCTGCACTGGCTG-3&#8242;</td>
###xml 1545 1545 1545 1545 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1500 1545 1500 1545 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">R9160A-F</td><td rowspan="1" colspan="1">5&#8242;-GCTGTTCTGCCCTTCGCTCCTGCACTGGCTG-3&#8242;</td><td rowspan="1" colspan="1"/></tr>
###xml 1545 1553 1545 1553 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">R9160A-R</td>
###xml 1553 1590 1553 1590 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-CAGCCAGTGCAGGAGCGAAGGGCAGAACAGC-3&#8242;</td>
###xml 1590 1590 1590 1590 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1545 1590 1545 1590 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">R9160A-R</td><td rowspan="1" colspan="1">5&#8242;-CAGCCAGTGCAGGAGCGAAGGGCAGAACAGC-3&#8242;</td><td rowspan="1" colspan="1"/></tr>
###xml 1601 1606 1601 1606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mMLH1</italic>
###xml 1590 1606 1590 1606 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">PET24a (+)-<italic>mMLH1</italic></td>
###xml 1606 1644 1606 1644 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATTCGCGGATCCATGGCGTTTGTAGCAGGAGT-3&#8242;</td>
###xml 1644 1649 1644 1649 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">BamHI</td>
###xml 1590 1649 1590 1649 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">PET24a (+)-<italic>mMLH1</italic></td><td rowspan="1" colspan="1">5&#8242;-ATTCGCGGATCCATGGCGTTTGTAGCAGGAGT-3&#8242;</td><td rowspan="1" colspan="1">BamHI</td></tr>
###xml 1649 1649 1649 1649 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1649 1688 1649 1688 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">5&#8242;-ATACGC GAATTCTTAACACCGCTCAAAGACTT-3&#8242;</td>
###xml 1688 1693 1688 1693 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">EcoRI</td>
###xml 1649 1693 1649 1693 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-ATACGC GAATTCTTAACACCGCTCAAAGACTT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr>
###xml 759 1693 759 1693 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">pFLAG-CMV2-<italic>hMLH1</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCATCGTTCGTGGCAGGGGTTAT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-ATACGCGGATCCTTAACACCTCTCAAAGACTT-3&#8242;</td><td rowspan="1" colspan="1">BamHI</td></tr><tr><td rowspan="1" colspan="1">pCDNA3-6HA-<italic>hMLH1</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCTCGTTCGTGGCAGGGGT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCTTAACACCTCTCAAAGAC-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1">pCDNA3-6HA-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGAAGTGCCTGGTCACGGGCGG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">(1-270)</td><td rowspan="1" colspan="1">5&#8242;GCGCGCGGATCCCTACGAGTCGGTGTCTGAGAGTG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">pCDNA3-6HA-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCGAATTCCACTCCCAGGACCTGGGCTC-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1">(271-391)</td><td rowspan="1" colspan="1">5&#8242;-GCGCGCGGATCCTCAGCCTTCACCCTCACTGT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGAAGTGCCTGGTCACGGGCGG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">(1-130)</td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTCACAGTCCTGGAAGGACA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGTCCCTGCAGGCCGTCTTCGA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">(131-270)</td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTAGTGCGAGTCGGTGTCTGAGA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATTCGGCTCGAGCCTGCACTGGCTG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">(161-270)</td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTAGTGCGAGTCGGTGTCTGAGA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">R9160A-F</td><td rowspan="1" colspan="1">5&#8242;-GCTGTTCTGCCCTTCGCTCCTGCACTGGCTG-3&#8242;</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">R9160A-R</td><td rowspan="1" colspan="1">5&#8242;-CAGCCAGTGCAGGAGCGAAGGGCAGAACAGC-3&#8242;</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PET24a (+)-<italic>mMLH1</italic></td><td rowspan="1" colspan="1">5&#8242;-ATTCGCGGATCCATGGCGTTTGTAGCAGGAGT-3&#8242;</td><td rowspan="1" colspan="1">BamHI</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-ATACGC GAATTCTTAACACCGCTCAAAGACTT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr></tbody>
###xml 728 1693 728 1693 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Plasmids</th><th rowspan="1" colspan="1">Primer</th><th rowspan="1" colspan="1">Restriction sites</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">pFLAG-CMV2-<italic>hMLH1</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCATCGTTCGTGGCAGGGGTTAT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-ATACGCGGATCCTTAACACCTCTCAAAGACTT-3&#8242;</td><td rowspan="1" colspan="1">BamHI</td></tr><tr><td rowspan="1" colspan="1">pCDNA3-6HA-<italic>hMLH1</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCTCGTTCGTGGCAGGGGT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCTTAACACCTCTCAAAGAC-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1">pCDNA3-6HA-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGAAGTGCCTGGTCACGGGCGG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">(1-270)</td><td rowspan="1" colspan="1">5&#8242;GCGCGCGGATCCCTACGAGTCGGTGTCTGAGAGTG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">pCDNA3-6HA-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCGAATTCCACTCCCAGGACCTGGGCTC-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1">(271-391)</td><td rowspan="1" colspan="1">5&#8242;-GCGCGCGGATCCTCAGCCTTCACCCTCACTGT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGAAGTGCCTGGTCACGGGCGG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">(1-130)</td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTCACAGTCCTGGAAGGACA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGTCCCTGCAGGCCGTCTTCGA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">(131-270)</td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTAGTGCGAGTCGGTGTCTGAGA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATTCGGCTCGAGCCTGCACTGGCTG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">(161-270)</td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTAGTGCGAGTCGGTGTCTGAGA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">R9160A-F</td><td rowspan="1" colspan="1">5&#8242;-GCTGTTCTGCCCTTCGCTCCTGCACTGGCTG-3&#8242;</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">R9160A-R</td><td rowspan="1" colspan="1">5&#8242;-CAGCCAGTGCAGGAGCGAAGGGCAGAACAGC-3&#8242;</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PET24a (+)-<italic>mMLH1</italic></td><td rowspan="1" colspan="1">5&#8242;-ATTCGCGGATCCATGGCGTTTGTAGCAGGAGT-3&#8242;</td><td rowspan="1" colspan="1">BamHI</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-ATACGC GAATTCTTAACACCGCTCAAAGACTT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr></tbody></table>
###xml 666 1693 666 1693 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1.</label><caption><p textid="19">Primers used to amplify cDNA for constructing plasmids</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Plasmids</th><th rowspan="1" colspan="1">Primer</th><th rowspan="1" colspan="1">Restriction sites</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">pFLAG-CMV2-<italic>hMLH1</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCATCGTTCGTGGCAGGGGTTAT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-ATACGCGGATCCTTAACACCTCTCAAAGACTT-3&#8242;</td><td rowspan="1" colspan="1">BamHI</td></tr><tr><td rowspan="1" colspan="1">pCDNA3-6HA-<italic>hMLH1</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCTCGTTCGTGGCAGGGGT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-ATACGCGAATTCTTAACACCTCTCAAAGAC-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1">pCDNA3-6HA-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGAAGTGCCTGGTCACGGGCGG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">(1-270)</td><td rowspan="1" colspan="1">5&#8242;GCGCGCGGATCCCTACGAGTCGGTGTCTGAGAGTG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">pCDNA3-6HA-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCGAATTCCACTCCCAGGACCTGGGCTC-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1">(271-391)</td><td rowspan="1" colspan="1">5&#8242;-GCGCGCGGATCCTCAGCCTTCACCCTCACTGT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr><tr><td rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGAAGTGCCTGGTCACGGGCGG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">(1-130)</td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTCACAGTCCTGGAAGGACA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGTCCCTGCAGGCCGTCTTCGA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">(131-270)</td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTAGTGCGAGTCGGTGTCTGAGA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">pGEX-6P-1-<italic>hRad9</italic></td><td rowspan="1" colspan="1">5&#8242;-ATTCGGCTCGAGCCTGCACTGGCTG-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">(161-270)</td><td rowspan="1" colspan="1">5&#8242;-ATACCCCTCGAGCTAGTGCGAGTCGGTGTCTGAGA-3&#8242;</td><td rowspan="1" colspan="1">XhoI</td></tr><tr><td rowspan="1" colspan="1">R9160A-F</td><td rowspan="1" colspan="1">5&#8242;-GCTGTTCTGCCCTTCGCTCCTGCACTGGCTG-3&#8242;</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">R9160A-R</td><td rowspan="1" colspan="1">5&#8242;-CAGCCAGTGCAGGAGCGAAGGGCAGAACAGC-3&#8242;</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PET24a (+)-<italic>mMLH1</italic></td><td rowspan="1" colspan="1">5&#8242;-ATTCGCGGATCCATGGCGTTTGTAGCAGGAGT-3&#8242;</td><td rowspan="1" colspan="1">BamHI</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">5&#8242;-ATACGC GAATTCTTAACACCGCTCAAAGACTT-3&#8242;</td><td rowspan="1" colspan="1">EcoRI</td></tr></tbody></table></table-wrap>
###xml 130 135 <span type="species:ncbi:9606">human</span>
Two vectors, pCDNA3-6HA (30) and pFLAG-CMV2 (Sigma, St Louis, MO), were used to construct plasmids capable of expressing hMLH1 in human cells. To make pCDNA3-6HA-hMLH1, pFLAG-CMV2-hMLH1, the cDNA of the hMLH1 gene was amplified by PCR from the plasmid pEGFP-hMLH1 (a kind gift from Dr. Lene Juel Rasmussen, Roskilde University, Denmark). The sequences of forward and reverse primers for these PCR reactions are given in Table 1. The hMLH1 gene was cloned between the EcoRI and BamHI sites of pFLAG-CMV2, and in the EcoRI site of pCDNA3-6HA. The pCDNA3-6HA and pFLAG-CMV2 constructs bearing the Hus1, Rad1 or Rad9 open reading frame were constructed previously (30). Table 1.Primers used to amplify cDNA for constructing plasmidsPlasmidsPrimerRestriction sitespFLAG-CMV2-hMLH15'-ATACGCGAATTCATCGTTCGTGGCAGGGGTTAT-3'EcoRI5'-ATACGCGGATCCTTAACACCTCTCAAAGACTT-3'BamHIpCDNA3-6HA-hMLH15'-ATACGCGAATTCTCGTTCGTGGCAGGGGT-3'EcoRI5'-ATACGCGAATTCTTAACACCTCTCAAAGAC-3'EcoRIpCDNA3-6HA-hRad95'-ATACCCCTCGAGAAGTGCCTGGTCACGGGCGG-3'XhoI(1-270)5'GCGCGCGGATCCCTACGAGTCGGTGTCTGAGAGTG-3'XhoIpCDNA3-6HA-hRad95'-ATACCCGAATTCCACTCCCAGGACCTGGGCTC-3'EcoRI(271-391)5'-GCGCGCGGATCCTCAGCCTTCACCCTCACTGT-3'EcoRIpGEX-6P-1-hRad95'-ATACCCCTCGAGAAGTGCCTGGTCACGGGCGG-3'XhoI(1-130)5'-ATACCCCTCGAGCTCACAGTCCTGGAAGGACA-3'XhoIpGEX-6P-1-hRad95'-ATACCCCTCGAGTCCCTGCAGGCCGTCTTCGA-3'XhoI(131-270)5'-ATACCCCTCGAGCTAGTGCGAGTCGGTGTCTGAGA-3'XhoIpGEX-6P-1-hRad95'-ATTCGGCTCGAGCCTGCACTGGCTG-3'XhoI(161-270)5'-ATACCCCTCGAGCTAGTGCGAGTCGGTGTCTGAGA-3'XhoIR9160A-F5'-GCTGTTCTGCCCTTCGCTCCTGCACTGGCTG-3'R9160A-R5'-CAGCCAGTGCAGGAGCGAAGGGCAGAACAGC-3'PET24a (+)-mMLH15'-ATTCGCGGATCCATGGCGTTTGTAGCAGGAGT-3'BamHI5'-ATACGC GAATTCTTAACACCGCTCAAAGACTT-3'EcoRI
###end p 18
###begin p 19
Primers used to amplify cDNA for constructing plasmids
###end p 19
###begin p 20
###xml 395 397 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human embryonic kidney 293T cells were transfected with the plasmids of interest using Lipofectamine plus (Invitrogen, USA). Cells were grown to 60-80% confluence in 60 mm tissue culture dishes and transfected with 1.5 mug pFLAG-CMV2 DNA and 1.5 mug pCDNA3-6HA DNA following the procedure described by Invitrogen. Immunoprecipitation and Western blotting were performed as described previously (31).
###end p 20
###begin title 21
Construction of the hRad9 S160A mutant
###end title 21
###begin p 22
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 194 201 194 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 271 284 271 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9 (S160A)</italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
pGEX-6P-1-hRad9 (S160A) was derived from pGEX-6P-1-hRad9 following the QuickChange mutagenesis procedure (Stratagene). The primers for the mutagenesis PCR of S160A were R9160A-F and R9160A-R in Table 1. The mutant was confirmed by DNA sequencing. The plasmid of pZeoSV2- hRad9 (S160A) was constructed by cutting from pGEX-6P-1-hRad9 (S160A) and inserting into the XhoI site of pZeoSV2 (Invitrogen, USA).
###end p 22
###begin title 23
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro pull-down tests
###end title 23
###begin p 24
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 348 353 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 476 483 476 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 595 600 595 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 621 626 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 636 641 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 656 661 656 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 687 692 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 798 803 798 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 901 906 <span type="species:ncbi:10090">Mouse</span>
###xml 936 941 <span type="species:ncbi:10090">mouse</span>
The full-length hRad9 cDNA removed from pCDNA3-6HA-hRad9 using XhoI was inserted into the XhoI site of pGEX-6P-1 (GE Health) to make pGEX-6P-1-hRad9. The hMLH1 open reading frame was cut from pCDNA3-6HA-hMLH1 using EcoRI and inserted into the EcoRI site of pET24a (+) (Novagen) to make pET24a (+)-hMLH1, and inserted in pGEX-6P-1 to make pGEX-6P-1-hMLH1. The truncated hRad9 and hMLH1 constructs were amplified by PCR using template pGEX-6P-1-hRad9. The primers are listed in Table 1. The PCR products of hRad9 were digested with XhoI and ligated with XhoI-digested pGEX-6P-1 to yield pGEX-6P-1-hRad9 plasmids containing hRad9 (1-130), hRad9 (131-270) and hRad9 (161-270). The pGEX-6P-1-hRad9 (1-270) and pGEX-6P-1-hRad9 (271-391) plasmids were derived from pCDNA3-6HA-hRad9 (1-270) and pCDNA3-6HA-hRad9 (271-391) in the same way as described above. Cloned sequences were confirmed by DNA sequencing. Mouse MLH1 cDNA was amplified from mouse ES cell cDNA and inserted into BamHI and EcoRI sites of pET24a (+) to make pET24a (+)-mMLH1.
###end p 24
###begin p 25
###xml 300 303 292 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
###xml 622 623 602 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
For the expression of GST tagged hRad9 fragments and His-hMLH1, Rosetta cells (Invitrogen) harboring expression plasmids were cultured in LB broth containing 100 mug/ml of ampicillin for GST tagged proteins or 50 mug/ml of kanamycin for His-hMLH1 at 37degreesC. Protein expression was induced at an A600 of 0.6 by the addition of isopropytlthiogalactoside (IPTG) to a final concentration of 0.4 mM and cells were grown at 16degreesC for 24 h and then harvested. The cell paste, from a 500-ml culture, was resuspended in 10 ml PBS containing 1 mM PMSF at 4degreesC. After sonication, the solution was centrifuged at 16 000 g for 30 min and the supernatant was saved.
###end p 25
###begin p 26
###xml 277 278 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
For purification of the GST tagged protein, 1 ml of a 50% slurry of glutathione-Sepharose 4B (GE Healthcare) in PBS buffer with 1% Triton X-100 was added to 10 ml supernatant and incubated overnight at 4degreesC. The GST-tagged proteins bound to the beads were pelleted at 500 g for 5 min and washed three times with 1 ml PBS buffer containing 1% Triton X-100 and then eluted with 10 mM reduced L-glutathione in 50 mM Tris-HCl, pH8.0.
###end p 26
###begin p 27
To purify His-hMLH1, the supernatant was added to a 50% slurry of Ni Sepharose High Performance (Amersham Biosciences) and eluted in a stepwise manner with 1.6 ml (0.4 ml x 4 times each) of 10, 25, 50, 100 and 250 mM imidazole in 50 mM Na-phosphate buffer, pH 7.5.
###end p 27
###begin p 28
###xml 238 239 237 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 334 335 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
His-tagged hMLH1 expressed in Rosetta cells was added to the appropriate GST-tagged proteins (100 ng) immobilized on glutathione-Sepharose 4B and incubated for 1 h in 500 mul binding buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM MgCl2, 10% glycerol, 1% Triton X-100, 0.5 mM DTT, 1% BSA) at 4degreesC. After centrifugation at 500 g for 5 min, the pellets were washed five times with 500 mul of binding buffer at 4degreesC and fractionated on a 10% SDS-polyacrylamide gel. Western blots for hMLH1 were probed with anti-hMLH1 antibody (BD Biosciences Pharmingen, Franklin Lake, NJ). A control of immobilized GST alone was run concurrently.
###end p 28
###begin title 29
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast two-hybrid analysis
###end title 29
###begin p 30
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 438 443 <span type="species:ncbi:4932">Yeast</span>
The matchmaker LexA two-hybrid system from Clontech was used to determine the interaction of hMLH1 and hRad9. pLexA and pB42AD plasmids containing the hRad9 sequence were constructed previously (30). The full-length coding sequence of hMLH1 was amplified by PCR from pACJ112 (a gift from Dr Lene Juel Rasmussen, Roskilde University, Denmark). The PCR product was digested with EcoRI and inserted into the EcoRI sites of pLexA and pB42AD. Yeast two-hybrid analyses were performed using a previously published procedure (30).
###end p 30
###begin title 31
Tests for MMR activity
###end title 31
###begin p 32
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 34 36 34 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 212 218 212 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 365 366 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 914 915 912 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1163 1169 1161 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1171 1173 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1321 1326 1319 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 1528 1530 1526 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 658 666 <span type="species:ncbi:9606">Children</span>
###xml 1376 1381 <span type="species:ncbi:10090">Mouse</span>
A method developed by Lei et al. (32) to detect MMR activity in living cells was used with minor modifications. The DNA substrates, homoduplex and heteroduplex EGFP plasmids, were prepared in the same way as Lei et al. (32). Lipofectamine reagents (Invitrogen) were used to transfect DNA into cultured cells. Cells were plated on 60-mm dishes at a density of 5 x 105 cells/dish. Transfection was performed the following day according to the manufacturer's protocols. Homoduplex or heteroduplex EGFP plasmid measuring 0.2 mug was co-transfected with 0.2 mug red fluorescent protein (RFP) expression plasmid pmRFP-C1 (a kind gift from Dr. Liusheng He, St Jude Children's Research Hospital, Memphis, TN, USA). pmRFP-C1 was used to ascertain that the transfection efficiencies of the EGFP plasmids were comparable. The cells were trypsinized 20 h after transfection, and resuspended in PBS at a concentration of 5 x 105 cells/ml. 30 000 cells were measured for their fluorescence intensities at wavelengths of 530/30 nm (green) and above 670 nm (red) using a FACSCalibur flow cytometer (Becton Dickinson). MMR activity was calculated using a formula developed by Lei et al. (32). HCT116 cells do not express functional hMLH1 and therefore have an impaired MMR system. HCT116 cells transfected with pFLAG-CMV2 and pFLAG-CMV2 -hMLH1 were used as negative and positive MMR controls. Mouse ES cells were transfected in the same way as described above for HCT116 cells except for the use of a specialized medium for culture of ES cells (17).
###end p 32
###begin title 33
ES cell survival and cell cycle checkpoint assays
###end title 33
###begin p 34
###xml 158 159 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 164 166 163 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">60</sup>
###xml 225 227 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse ES cells were seeded at various concentrations in duplicate on gelatinized tissue culture dishes. Sensitivities to 250 muM HU, 254-nm UV light at 10 J/m2 and 60Co gamma rays at 6 Gy were tested as described previously (17). Survival against MMS and MNU were evaluated by counting colonies formed with and without mutagen treatment. Cells were incubated for 24 h after seeding in duplicated 60-mm dishes and then exposed to various concentrations of MMS or MNU for 1 h at 37degreesC in an incubator. The medium was removed, the cells were rinsed once with PBS, and fresh medium was added. Colonies formed after 1 week of growth were stained with Giemsa and counted. Relative colony formation (%) was expressed as colonies per treatment level/colonies that appeared in the control.
###end p 34
###begin p 35
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 341 342 335 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 429 435 <span type="species:ncbi:9986">rabbit</span>
###xml 491 497 <span type="species:ncbi:9986">rabbit</span>
The assay for G2/M checkpoint control of mouse ES cells induced by gamma rays was conducted as described in a previous study (17). A previously developed method was utilized to evaluate S/M checkpoint function (33). Briefly, 1 mM HU was added to ES cells when they were grown to 70% confluence. Cells were incubated at 37degreesC under 5% CO2 for designated times, then processed and suspended in PBS. The cells were probed with rabbit anti-phospho-histone H3 (Upstate)/FITC-conjugated anti-rabbit antibodies (Jackson ImmunoResearch Laboratories, INC), and stained with PI followed by flow cytometric analysis.
###end p 35
###begin title 36
RESULTS
###end title 36
###begin title 37
hRad9 interacts physically with hMLH1
###end title 37
###begin p 38
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 22 24 22 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 977 985 977 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1579 1584 1579 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35 B36 B37 B38 B39 B40 B41 B42 B43 B44 B45">35&#8211;45</xref>
###xml 1773 1782 1773 1782 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1812 1813 1812 1813 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2367 2368 2367 2368 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2525 2526 2525 2526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 2879 2880 2879 2880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1782 3099 1782 3099 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="39">hRad9 associates with hMLH1. (<bold>A</bold>) Silver-staining of hRad9-associated proteins. 293T cells stably expressing FLAG-hRad9 were immunoprecipitated with antibody against FLAG M2. Samples were resolved by 10% SDS&#8211;PAGE and visualized by silver staining (lane 2). Lane 1 is a negative control in which the immunoprecipitation was performed in 293T cells stably expressing FLAG-GFP. The bands of interest were cut and analyzed by a Mass-Spectrometer, hMLH1 (arrow) was identified to be one of the partners of hRad9. The protein bands of CAD, HSP110, hRad9, hHus1 and hRad1 are also indicated. (<bold>B</bold>) Co-immunoprecipitation of hRad9 and hMLH1. In the upper panel, endogenous hRad9 was immunoprecipitated with an anti-hMLH1 antibody from cell extracts of 10<sup>6</sup> HeLa cells, but not with pre-immune antiserum (lane 2). The immunoprecipitated proteins were detected with antibodies against hMLH1 (upper) and hRad9 (lower). Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. In the lower panel, endogenous hMLH1 was immunoprecipitated from cell extracts of 10<sup>6</sup> HeLa cells with an anti-hRad9 antibody (lane 3), but not with pre-immune serum (lane 2). The immunoprecipitated proteins were visualized by western blot analysis with antibodies against hMLH1 (upper) and hRad9 (lower).</p>
###xml 1782 3099 1782 3099 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="39">hRad9 associates with hMLH1. (<bold>A</bold>) Silver-staining of hRad9-associated proteins. 293T cells stably expressing FLAG-hRad9 were immunoprecipitated with antibody against FLAG M2. Samples were resolved by 10% SDS&#8211;PAGE and visualized by silver staining (lane 2). Lane 1 is a negative control in which the immunoprecipitation was performed in 293T cells stably expressing FLAG-GFP. The bands of interest were cut and analyzed by a Mass-Spectrometer, hMLH1 (arrow) was identified to be one of the partners of hRad9. The protein bands of CAD, HSP110, hRad9, hHus1 and hRad1 are also indicated. (<bold>B</bold>) Co-immunoprecipitation of hRad9 and hMLH1. In the upper panel, endogenous hRad9 was immunoprecipitated with an anti-hMLH1 antibody from cell extracts of 10<sup>6</sup> HeLa cells, but not with pre-immune antiserum (lane 2). The immunoprecipitated proteins were detected with antibodies against hMLH1 (upper) and hRad9 (lower). Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. In the lower panel, endogenous hMLH1 was immunoprecipitated from cell extracts of 10<sup>6</sup> HeLa cells with an anti-hRad9 antibody (lane 3), but not with pre-immune serum (lane 2). The immunoprecipitated proteins were visualized by western blot analysis with antibodies against hMLH1 (upper) and hRad9 (lower).</p></caption>
###xml 3099 3099 3099 3099 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn686f1"/>
###xml 1773 3099 1773 3099 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="39">hRad9 associates with hMLH1. (<bold>A</bold>) Silver-staining of hRad9-associated proteins. 293T cells stably expressing FLAG-hRad9 were immunoprecipitated with antibody against FLAG M2. Samples were resolved by 10% SDS&#8211;PAGE and visualized by silver staining (lane 2). Lane 1 is a negative control in which the immunoprecipitation was performed in 293T cells stably expressing FLAG-GFP. The bands of interest were cut and analyzed by a Mass-Spectrometer, hMLH1 (arrow) was identified to be one of the partners of hRad9. The protein bands of CAD, HSP110, hRad9, hHus1 and hRad1 are also indicated. (<bold>B</bold>) Co-immunoprecipitation of hRad9 and hMLH1. In the upper panel, endogenous hRad9 was immunoprecipitated with an anti-hMLH1 antibody from cell extracts of 10<sup>6</sup> HeLa cells, but not with pre-immune antiserum (lane 2). The immunoprecipitated proteins were detected with antibodies against hMLH1 (upper) and hRad9 (lower). Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. In the lower panel, endogenous hMLH1 was immunoprecipitated from cell extracts of 10<sup>6</sup> HeLa cells with an anti-hRad9 antibody (lane 3), but not with pre-immune serum (lane 2). The immunoprecipitated proteins were visualized by western blot analysis with antibodies against hMLH1 (upper) and hRad9 (lower).</p></caption><graphic xlink:href="gkn686f1"/></fig>
###xml 569 574 <span type="species:ncbi:9606">human</span>
Lindsey-Boltz et al. (34) reported that when FLAG tagged hRad9 expressed in HEK293T cells was purified with anti-FLAG agarose, carbamoyl phosphate synthetase/aspartate transcarbamoylase/dihydroorotase (CAD) and HSP110 were copurified with hRad9. Since mammalian Rad9 plays critical roles in multiple formats of DNA repair and cell cycle checkpoint control, Rad9 is very likely to interact with other proteins that are important for DNA repair and cell cycle checkpoint control. Therefore, we performed a similar but more careful immunoprecipitation assay to search for human proteins capable of interacting with hRad9. To enhance the sensitivity and reduce background noise, we established HEK293T cell clones stably expressing FLAG-tagged hRad9 and picked a clone that expressed FLAG-hRad9 at a level lower than the endogenous hRad9 level (data not shown). The affinity-purified proteins associated with FLAG-hRad9 were fractioned by SDS-PAGE and revealed by silver staining (Figure 1A). The bands of interest which were not seen in the affinity-purified extracts from control HEK293T cells stably expressing FLAG-GFP, were cut out, digested and analyzed with LC-MS/MS. LC-MS/MS analysis of hRad9-copurified bands revealed that besides CAD and HSP110, there were other proteins not previously reported to interact with hRad9. As expected, hHus1 and hRad1 were also purified together with hRad9. One of these proteins was hMLH1, a protein essential for DNA MMR. hRad9 has been reported to interact with several DNA repair proteins involved in HR repair and base-excision repair (35-45), but none of the proteins involved in MMR have previously been found to associate with Rad9. Therefore, we chose to characterize this interaction and its functional significance further. Figure 1.hRad9 associates with hMLH1. (A) Silver-staining of hRad9-associated proteins. 293T cells stably expressing FLAG-hRad9 were immunoprecipitated with antibody against FLAG M2. Samples were resolved by 10% SDS-PAGE and visualized by silver staining (lane 2). Lane 1 is a negative control in which the immunoprecipitation was performed in 293T cells stably expressing FLAG-GFP. The bands of interest were cut and analyzed by a Mass-Spectrometer, hMLH1 (arrow) was identified to be one of the partners of hRad9. The protein bands of CAD, HSP110, hRad9, hHus1 and hRad1 are also indicated. (B) Co-immunoprecipitation of hRad9 and hMLH1. In the upper panel, endogenous hRad9 was immunoprecipitated with an anti-hMLH1 antibody from cell extracts of 106 HeLa cells, but not with pre-immune antiserum (lane 2). The immunoprecipitated proteins were detected with antibodies against hMLH1 (upper) and hRad9 (lower). Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. In the lower panel, endogenous hMLH1 was immunoprecipitated from cell extracts of 106 HeLa cells with an anti-hRad9 antibody (lane 3), but not with pre-immune serum (lane 2). The immunoprecipitated proteins were visualized by western blot analysis with antibodies against hMLH1 (upper) and hRad9 (lower).
###end p 38
###begin p 39
###xml 30 31 30 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 585 586 585 586 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 743 744 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1097 1098 1097 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
hRad9 associates with hMLH1. (A) Silver-staining of hRad9-associated proteins. 293T cells stably expressing FLAG-hRad9 were immunoprecipitated with antibody against FLAG M2. Samples were resolved by 10% SDS-PAGE and visualized by silver staining (lane 2). Lane 1 is a negative control in which the immunoprecipitation was performed in 293T cells stably expressing FLAG-GFP. The bands of interest were cut and analyzed by a Mass-Spectrometer, hMLH1 (arrow) was identified to be one of the partners of hRad9. The protein bands of CAD, HSP110, hRad9, hHus1 and hRad1 are also indicated. (B) Co-immunoprecipitation of hRad9 and hMLH1. In the upper panel, endogenous hRad9 was immunoprecipitated with an anti-hMLH1 antibody from cell extracts of 106 HeLa cells, but not with pre-immune antiserum (lane 2). The immunoprecipitated proteins were detected with antibodies against hMLH1 (upper) and hRad9 (lower). Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. In the lower panel, endogenous hMLH1 was immunoprecipitated from cell extracts of 106 HeLa cells with an anti-hRad9 antibody (lane 3), but not with pre-immune serum (lane 2). The immunoprecipitated proteins were visualized by western blot analysis with antibodies against hMLH1 (upper) and hRad9 (lower).
###end p 39
###begin p 40
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 343 351 343 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
To confirm the association of hMLH1 and hRad9 in vivo, co-immunoprecipitation was performed using an anti-hMLH1 monoclonal antibody or anti-hRad9 polyclonal antibodies. hRad9 and hMLH1 were immunoprecipitated together from the extracts of HeLa cells by either the anti-hMLH1 antibody or the anti-hRad9 antibodies, but not by pre-immune serum (Figure 1B). This result indicates that hRad9 and hMLH1 are associated together in cells.
###end p 40
###begin p 41
###xml 235 243 235 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 360 368 360 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 602 607 602 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 619 624 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 694 702 694 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 745 750 745 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 782 787 782 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 874 879 874 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hHus1</italic>
###xml 891 896 891 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 931 933 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1061 1066 1061 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 1078 1083 1078 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 1230 1239 1230 1239 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 1277 1278 1277 1278 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1793 1794 1787 1788 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1931 1961 1925 1955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae EGY48</italic>
###xml 1239 2099 1239 2093 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="42">hRad9 interacts with hMLH1 directly. (<bold>A</bold>) GST pull-down assay. One microgram GST-hMLH1 (lane 3) or an equal amount of GST alone (lane 2) was immobilized on glutathione-Sepharose and incubated with purified His-hRad9 (100 ng) in binding buffer for 2 h at 4&#176;C. The Sepharose was washed five times with binding buffer. The purified proteins were subjected to western blot analysis and probed with the hRad9 antibody. Lane 1 contains 10 ng (10% of the total input) of His-hRad9. Unlike GST (lane 2), GST-hMLH1 (lane 3) was able to pull down His-hRad9. (<bold>B</bold>) Interactions of hRad9 and hMLH1 in a yeast two-hybrid assay. The pairs of two-hybrid recombinant proteins tested in each population of <italic>Saccharomyces cerevisiae EGY48</italic> host cells were arranged as follows: (left) pLexA-gene 1/(right) pB42AD-gene 2. BD-hMLH1 was able to interact specifically with AD-hRad9.</p>
###xml 1239 2099 1239 2093 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="42">hRad9 interacts with hMLH1 directly. (<bold>A</bold>) GST pull-down assay. One microgram GST-hMLH1 (lane 3) or an equal amount of GST alone (lane 2) was immobilized on glutathione-Sepharose and incubated with purified His-hRad9 (100 ng) in binding buffer for 2 h at 4&#176;C. The Sepharose was washed five times with binding buffer. The purified proteins were subjected to western blot analysis and probed with the hRad9 antibody. Lane 1 contains 10 ng (10% of the total input) of His-hRad9. Unlike GST (lane 2), GST-hMLH1 (lane 3) was able to pull down His-hRad9. (<bold>B</bold>) Interactions of hRad9 and hMLH1 in a yeast two-hybrid assay. The pairs of two-hybrid recombinant proteins tested in each population of <italic>Saccharomyces cerevisiae EGY48</italic> host cells were arranged as follows: (left) pLexA-gene 1/(right) pB42AD-gene 2. BD-hMLH1 was able to interact specifically with AD-hRad9.</p></caption>
###xml 2099 2099 2093 2093 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn686f2"/>
###xml 1230 2099 1230 2093 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="42">hRad9 interacts with hMLH1 directly. (<bold>A</bold>) GST pull-down assay. One microgram GST-hMLH1 (lane 3) or an equal amount of GST alone (lane 2) was immobilized on glutathione-Sepharose and incubated with purified His-hRad9 (100 ng) in binding buffer for 2 h at 4&#176;C. The Sepharose was washed five times with binding buffer. The purified proteins were subjected to western blot analysis and probed with the hRad9 antibody. Lane 1 contains 10 ng (10% of the total input) of His-hRad9. Unlike GST (lane 2), GST-hMLH1 (lane 3) was able to pull down His-hRad9. (<bold>B</bold>) Interactions of hRad9 and hMLH1 in a yeast two-hybrid assay. The pairs of two-hybrid recombinant proteins tested in each population of <italic>Saccharomyces cerevisiae EGY48</italic> host cells were arranged as follows: (left) pLexA-gene 1/(right) pB42AD-gene 2. BD-hMLH1 was able to interact specifically with AD-hRad9.</p></caption><graphic xlink:href="gkn686f2"/></fig>
###xml 484 489 <span type="species:ncbi:4932">yeast</span>
###xml 635 640 <span type="species:ncbi:4932">yeast</span>
###xml 716 721 <span type="species:ncbi:4932">yeast</span>
###xml 848 853 <span type="species:ncbi:4932">yeast</span>
###xml 1041 1046 <span type="species:ncbi:4932">yeast</span>
###xml 1833 1838 <span type="species:ncbi:4932">yeast</span>
###xml 1931 1955 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
We next determined whether the interaction between hRad9 and hMLH1 was direct, rather than being mediated via accessory proteins. GST pull-down was performed to test whether purified recombinant hRad9 and hMLH1 could interact directly in vitro. GST-hMLH1 fusion protein bound to glutathione-Sepharose was incubated with purified His-hRad9 protein. As shown in Figure 2A, hRad9 could be pulled down by GST-hMLH1 (lane 3), while hRad9 did not bind to GST alone (lane 2). Furthermore, a yeast two-hybridization assay was also performed to assess the interaction of hRad9 and hMLH1. Co-expression of pLexA-hMLH1 and pB42AD-hRad9 supported yeast growth and turned colorless X-gal into blue product (Figure 2B), while the yeast cells containing pLexA-hMLH1 and pB42AD or pLexA and pB42AD-hRad9 did not grow and remained colorless. As a positive control, yeast cells bearing pLexA-hHus1 and pB42AD-hRad9 grew and turned blue as expected (30). These results again support the idea that hRad9 interacts with hMLH1 directly. It is noteworthy that the yeast bearing pLexA-hRad9 and pB42AD-hMLH1 did not grow and remained colorless, suggesting that hRad9 and hMLH1 interact physically only when the protein contact is in the right direction. Figure 2.hRad9 interacts with hMLH1 directly. (A) GST pull-down assay. One microgram GST-hMLH1 (lane 3) or an equal amount of GST alone (lane 2) was immobilized on glutathione-Sepharose and incubated with purified His-hRad9 (100 ng) in binding buffer for 2 h at 4degreesC. The Sepharose was washed five times with binding buffer. The purified proteins were subjected to western blot analysis and probed with the hRad9 antibody. Lane 1 contains 10 ng (10% of the total input) of His-hRad9. Unlike GST (lane 2), GST-hMLH1 (lane 3) was able to pull down His-hRad9. (B) Interactions of hRad9 and hMLH1 in a yeast two-hybrid assay. The pairs of two-hybrid recombinant proteins tested in each population of Saccharomyces cerevisiae EGY48 host cells were arranged as follows: (left) pLexA-gene 1/(right) pB42AD-gene 2. BD-hMLH1 was able to interact specifically with AD-hRad9.
###end p 41
###begin p 42
###xml 38 39 38 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 554 555 548 549 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 692 722 686 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae EGY48</italic>
###xml 594 599 <span type="species:ncbi:4932">yeast</span>
###xml 692 716 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
hRad9 interacts with hMLH1 directly. (A) GST pull-down assay. One microgram GST-hMLH1 (lane 3) or an equal amount of GST alone (lane 2) was immobilized on glutathione-Sepharose and incubated with purified His-hRad9 (100 ng) in binding buffer for 2 h at 4degreesC. The Sepharose was washed five times with binding buffer. The purified proteins were subjected to western blot analysis and probed with the hRad9 antibody. Lane 1 contains 10 ng (10% of the total input) of His-hRad9. Unlike GST (lane 2), GST-hMLH1 (lane 3) was able to pull down His-hRad9. (B) Interactions of hRad9 and hMLH1 in a yeast two-hybrid assay. The pairs of two-hybrid recombinant proteins tested in each population of Saccharomyces cerevisiae EGY48 host cells were arranged as follows: (left) pLexA-gene 1/(right) pB42AD-gene 2. BD-hMLH1 was able to interact specifically with AD-hRad9.
###end p 42
###begin title 43
hMLH1 does not interact with hRad1 and hHus1
###end title 43
###begin p 44
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7 B8 B9 B10 B11">7&#8211;11</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 183 188 183 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46 B47 B48">46&#8211;48</xref>
###xml 392 400 392 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 500 509 500 509 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 567 572 567 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 645 650 643 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad1</italic>
###xml 687 692 684 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 732 737 728 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hHus1</italic>
###xml 509 1124 509 1120 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="45">hMLH1 is not associated with hRad1 or hHus1. pCDNA3.0-6HA-<italic>hMLH1</italic> (1.5 &#956;g) was transfected into 293T cells along with 1.5 &#956;g pFLAG-CMV2-<italic>hRad1</italic> (lanes 1 and 4), 1.5 &#956;g pFLAG-CMV2-<italic>hRad9</italic> (lanes 2 and 5) and 1.5 &#956;g pFLAG-CMV2-<italic>hHus1</italic> (lanes 3 and 6), respectively. Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. The lysate was immunoprecipitated with anti-FLAG antibody, and the western blot membrane was probed with an antibody against HA (upper) and against FLAG (lower). The anti-FLAG antibody was able to precipitate HA-hMLH1 mediated only by FLAG-hRad9.</p>
###xml 509 1124 509 1120 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="45">hMLH1 is not associated with hRad1 or hHus1. pCDNA3.0-6HA-<italic>hMLH1</italic> (1.5 &#956;g) was transfected into 293T cells along with 1.5 &#956;g pFLAG-CMV2-<italic>hRad1</italic> (lanes 1 and 4), 1.5 &#956;g pFLAG-CMV2-<italic>hRad9</italic> (lanes 2 and 5) and 1.5 &#956;g pFLAG-CMV2-<italic>hHus1</italic> (lanes 3 and 6), respectively. Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. The lysate was immunoprecipitated with anti-FLAG antibody, and the western blot membrane was probed with an antibody against HA (upper) and against FLAG (lower). The anti-FLAG antibody was able to precipitate HA-hMLH1 mediated only by FLAG-hRad9.</p></caption>
###xml 1124 1124 1120 1120 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn686f3"/>
###xml 500 1124 500 1120 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="45">hMLH1 is not associated with hRad1 or hHus1. pCDNA3.0-6HA-<italic>hMLH1</italic> (1.5 &#956;g) was transfected into 293T cells along with 1.5 &#956;g pFLAG-CMV2-<italic>hRad1</italic> (lanes 1 and 4), 1.5 &#956;g pFLAG-CMV2-<italic>hRad9</italic> (lanes 2 and 5) and 1.5 &#956;g pFLAG-CMV2-<italic>hHus1</italic> (lanes 3 and 6), respectively. Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. The lysate was immunoprecipitated with anti-FLAG antibody, and the western blot membrane was probed with an antibody against HA (upper) and against FLAG (lower). The anti-FLAG antibody was able to precipitate HA-hMLH1 mediated only by FLAG-hRad9.</p></caption><graphic xlink:href="gkn686f3"/></fig>
Given that hMLH1 interacts with hRad9, we asked whether hMLH1 interacted with hRad1 and hHus1, the two other proteins that form a heterotrimer (the 9-1-1 complex) with hRad9 (7-11,30,46-48). A co-immunoprecipitation assay showed that overexpressed HA-tagged hRad1 and hHus1 did not interact with FLAG-tagged hMLH1, while as a positive control, HA-hRad9 was found to interact with FLAG-hMLH1 (Figure 3). These findings suggest that hMLH1 binds to free hRad9 but not to hRad9 within the 9-1-1 complex. Figure 3.hMLH1 is not associated with hRad1 or hHus1. pCDNA3.0-6HA-hMLH1 (1.5 mug) was transfected into 293T cells along with 1.5 mug pFLAG-CMV2-hRad1 (lanes 1 and 4), 1.5 mug pFLAG-CMV2-hRad9 (lanes 2 and 5) and 1.5 mug pFLAG-CMV2-hHus1 (lanes 3 and 6), respectively. Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. The lysate was immunoprecipitated with anti-FLAG antibody, and the western blot membrane was probed with an antibody against HA (upper) and against FLAG (lower). The anti-FLAG antibody was able to precipitate HA-hMLH1 mediated only by FLAG-hRad9.
###end p 44
###begin p 45
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 136 141 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad1</italic>
###xml 178 183 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 223 228 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hHus1</italic>
hMLH1 is not associated with hRad1 or hHus1. pCDNA3.0-6HA-hMLH1 (1.5 mug) was transfected into 293T cells along with 1.5 mug pFLAG-CMV2-hRad1 (lanes 1 and 4), 1.5 mug pFLAG-CMV2-hRad9 (lanes 2 and 5) and 1.5 mug pFLAG-CMV2-hHus1 (lanes 3 and 6), respectively. Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. The lysate was immunoprecipitated with anti-FLAG antibody, and the western blot membrane was probed with an antibody against HA (upper) and against FLAG (lower). The anti-FLAG antibody was able to precipitate HA-hMLH1 mediated only by FLAG-hRad9.
###end p 45
###begin title 46
Mapping hRad9 domains required for its interaction with hMLH1
###end title 46
###begin p 47
###xml 529 537 529 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 824 832 824 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1030 1038 1030 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1266 1271 1266 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1271 1274 1271 1274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1518 1526 1518 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1600 1609 1600 1609 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1688 1689 1688 1689 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2065 2066 2052 2053 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2537 2538 2523 2524 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2813 2814 2799 2800 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2969 2977 2955 2963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1609 2979 1609 2965 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="48">Mapping of the hRad9 domain and amino acid residues that interact with hMLH1. (<bold>A</bold>) The map schematically illustrates the regions and amino acid residues of hRad9 that interact with hMLH1. The results are derived from the experimental data in Figure 4B&#8211;D. The intact hRad9 contains 391 amino acid residues. The point mutation is marked with a star. &#8216;+&#8217; stands for positive, &#8216;&#8212;&#8217;for negative and &#8216;&#8595;&#8217; for reduced interactions with hMLH1 or mMLH1. (<bold>B</bold>) Mapping the hRad9 region that interacted with His-hMLH1. Immobilized GST-hRad9, GST-hRad9 (1&#8211;270), GST-hRad9 (271&#8211;390), GST-hRad9 (1&#8211;130), GST-hRad9 (131&#8211;270), GST-hRad9 (161&#8211;270) and GST-hRad9 (S160A) (1 &#956;g in each case) were incubated with 100 ng purified His-hMLH1 and the western blot was probed with anti-hMLH1 antibody. A region between 131 and 160 was shown to be essential for hRad9&#8211;hMLH1 interaction, and Ser160 was shown to be critical for the interaction. (<bold>C</bold>) Graphic depiction of the polar amino acid residues in the 131&#8211;160 region of hRad9 that were mutated into alanine residues. Mutated residues are marked with stars. The italic and large sized &#8216;S&#8217; is used to label the Ser160 that is critical for the hRad9-hMLH1 interaction. (<bold>D</bold>) The hRad9 S160A point mutation also significantly reduced the interaction of human hRad9 with mouse mMLH1. The experimental procedure was the same as in <xref ref-type="fig" rid="F4">Figure 4</xref>B.</p>
###xml 1609 2979 1609 2965 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="48">Mapping of the hRad9 domain and amino acid residues that interact with hMLH1. (<bold>A</bold>) The map schematically illustrates the regions and amino acid residues of hRad9 that interact with hMLH1. The results are derived from the experimental data in Figure 4B&#8211;D. The intact hRad9 contains 391 amino acid residues. The point mutation is marked with a star. &#8216;+&#8217; stands for positive, &#8216;&#8212;&#8217;for negative and &#8216;&#8595;&#8217; for reduced interactions with hMLH1 or mMLH1. (<bold>B</bold>) Mapping the hRad9 region that interacted with His-hMLH1. Immobilized GST-hRad9, GST-hRad9 (1&#8211;270), GST-hRad9 (271&#8211;390), GST-hRad9 (1&#8211;130), GST-hRad9 (131&#8211;270), GST-hRad9 (161&#8211;270) and GST-hRad9 (S160A) (1 &#956;g in each case) were incubated with 100 ng purified His-hMLH1 and the western blot was probed with anti-hMLH1 antibody. A region between 131 and 160 was shown to be essential for hRad9&#8211;hMLH1 interaction, and Ser160 was shown to be critical for the interaction. (<bold>C</bold>) Graphic depiction of the polar amino acid residues in the 131&#8211;160 region of hRad9 that were mutated into alanine residues. Mutated residues are marked with stars. The italic and large sized &#8216;S&#8217; is used to label the Ser160 that is critical for the hRad9-hMLH1 interaction. (<bold>D</bold>) The hRad9 S160A point mutation also significantly reduced the interaction of human hRad9 with mouse mMLH1. The experimental procedure was the same as in <xref ref-type="fig" rid="F4">Figure 4</xref>B.</p></caption>
###xml 2979 2979 2965 2965 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn686f4"/>
###xml 1600 2979 1600 2965 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="48">Mapping of the hRad9 domain and amino acid residues that interact with hMLH1. (<bold>A</bold>) The map schematically illustrates the regions and amino acid residues of hRad9 that interact with hMLH1. The results are derived from the experimental data in Figure 4B&#8211;D. The intact hRad9 contains 391 amino acid residues. The point mutation is marked with a star. &#8216;+&#8217; stands for positive, &#8216;&#8212;&#8217;for negative and &#8216;&#8595;&#8217; for reduced interactions with hMLH1 or mMLH1. (<bold>B</bold>) Mapping the hRad9 region that interacted with His-hMLH1. Immobilized GST-hRad9, GST-hRad9 (1&#8211;270), GST-hRad9 (271&#8211;390), GST-hRad9 (1&#8211;130), GST-hRad9 (131&#8211;270), GST-hRad9 (161&#8211;270) and GST-hRad9 (S160A) (1 &#956;g in each case) were incubated with 100 ng purified His-hMLH1 and the western blot was probed with anti-hMLH1 antibody. A region between 131 and 160 was shown to be essential for hRad9&#8211;hMLH1 interaction, and Ser160 was shown to be critical for the interaction. (<bold>C</bold>) Graphic depiction of the polar amino acid residues in the 131&#8211;160 region of hRad9 that were mutated into alanine residues. Mutated residues are marked with stars. The italic and large sized &#8216;S&#8217; is used to label the Ser160 that is critical for the hRad9-hMLH1 interaction. (<bold>D</bold>) The hRad9 S160A point mutation also significantly reduced the interaction of human hRad9 with mouse mMLH1. The experimental procedure was the same as in <xref ref-type="fig" rid="F4">Figure 4</xref>B.</p></caption><graphic xlink:href="gkn686f4"/></fig>
###xml 1275 1280 <span type="species:ncbi:10090">mouse</span>
###xml 1387 1392 <span type="species:ncbi:9606">human</span>
###xml 1403 1408 <span type="species:ncbi:10090">mouse</span>
###xml 1431 1436 <span type="species:ncbi:10090">mouse</span>
###xml 1584 1589 <span type="species:ncbi:10090">mouse</span>
###xml 1593 1598 <span type="species:ncbi:9606">human</span>
###xml 2893 2898 <span type="species:ncbi:9606">human</span>
###xml 2910 2915 <span type="species:ncbi:10090">mouse</span>
To investigate which region of the hRad9 protein was responsible for mediating the interaction with hMLH1, a series of hRad9 deletion mutants were generated and tested for their abilities to interact with full-length hMLH1 in a GST pull-down assay, in which GST-tagged fragments of hRad9 were immobilized on glutathione-Sepharose and incubated with His-hMLH1, and as a negative control, GST alone with His-hMLH1 was included. Experimental results show that the hMLH1-interacting region of hRad9 is localized to residues 131-160 (Figure 4A and B). To narrow down which of these amino acid residues was important for the interaction of hRad9 with hMLH1, each of the polar amino acids on hRad9 in this region was mutated into alanine residues separately, and the mutants were subjected to a GST pull-down assay with His-hMLH1 (Figure 4C). We chose to only mutate polar residues to avoid disrupting the integrity of protein domains in hRad9. The results from the GST pull-down assay indicate that S160 of hRad9 (marked with a star in Figure 4A) is important for the interaction, and all the other polar amino acid residues in the 131-160 region have no or only very minor impact on the hRad9-hMLH1 interaction (data not shown). In one of the following sections, we used mRad9-/- mouse ES cells to test the functional importance of hRad9 in MMR, thus we also examined the interaction between human hRad9 and mouse mMLH1. As with hMLH1, mouse mMLH1 interacted directly with wild type hRad9, but not with mutant S160A hRad9 (Figure 4D), suggesting conservation of Rad9-MLH1 interaction from mouse to human. Figure 4.Mapping of the hRad9 domain and amino acid residues that interact with hMLH1. (A) The map schematically illustrates the regions and amino acid residues of hRad9 that interact with hMLH1. The results are derived from the experimental data in Figure 4B-D. The intact hRad9 contains 391 amino acid residues. The point mutation is marked with a star. '+' stands for positive, '-'for negative and 'downward arrow' for reduced interactions with hMLH1 or mMLH1. (B) Mapping the hRad9 region that interacted with His-hMLH1. Immobilized GST-hRad9, GST-hRad9 (1-270), GST-hRad9 (271-390), GST-hRad9 (1-130), GST-hRad9 (131-270), GST-hRad9 (161-270) and GST-hRad9 (S160A) (1 mug in each case) were incubated with 100 ng purified His-hMLH1 and the western blot was probed with anti-hMLH1 antibody. A region between 131 and 160 was shown to be essential for hRad9-hMLH1 interaction, and Ser160 was shown to be critical for the interaction. (C) Graphic depiction of the polar amino acid residues in the 131-160 region of hRad9 that were mutated into alanine residues. Mutated residues are marked with stars. The italic and large sized 'S' is used to label the Ser160 that is critical for the hRad9-hMLH1 interaction. (D) The hRad9 S160A point mutation also significantly reduced the interaction of human hRad9 with mouse mMLH1. The experimental procedure was the same as in Figure 4B.
###end p 47
###begin p 48
###xml 79 80 79 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 456 457 443 444 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 928 929 914 915 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1204 1205 1190 1191 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1360 1368 1346 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1284 1289 <span type="species:ncbi:9606">human</span>
###xml 1301 1306 <span type="species:ncbi:10090">mouse</span>
Mapping of the hRad9 domain and amino acid residues that interact with hMLH1. (A) The map schematically illustrates the regions and amino acid residues of hRad9 that interact with hMLH1. The results are derived from the experimental data in Figure 4B-D. The intact hRad9 contains 391 amino acid residues. The point mutation is marked with a star. '+' stands for positive, '-'for negative and 'downward arrow' for reduced interactions with hMLH1 or mMLH1. (B) Mapping the hRad9 region that interacted with His-hMLH1. Immobilized GST-hRad9, GST-hRad9 (1-270), GST-hRad9 (271-390), GST-hRad9 (1-130), GST-hRad9 (131-270), GST-hRad9 (161-270) and GST-hRad9 (S160A) (1 mug in each case) were incubated with 100 ng purified His-hMLH1 and the western blot was probed with anti-hMLH1 antibody. A region between 131 and 160 was shown to be essential for hRad9-hMLH1 interaction, and Ser160 was shown to be critical for the interaction. (C) Graphic depiction of the polar amino acid residues in the 131-160 region of hRad9 that were mutated into alanine residues. Mutated residues are marked with stars. The italic and large sized 'S' is used to label the Ser160 that is critical for the hRad9-hMLH1 interaction. (D) The hRad9 S160A point mutation also significantly reduced the interaction of human hRad9 with mouse mMLH1. The experimental procedure was the same as in Figure 4B.
###end p 48
###begin title 49
DNA mismatch-damage stimulates the hRad9-hMLH1 interaction
###end title 49
###begin p 50
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 91 92 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 109 110 109 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 148 149 148 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 249 250 249 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sub>
###xml 299 300 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 329 330 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 347 348 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 831 839 831 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1231 1240 1231 1240 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 1326 1327 1326 1327 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1623 1624 1623 1624 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1973 1974 1973 1974 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2110 2111 2110 2111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2115 2116 2115 2116 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2300 2301 2298 2299 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2353 2354 2351 2352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1240 2445 1240 2443 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="51">Interaction between hRad9 and hMLH1 is enhanced in response to MMS or MNU treatment. (<bold>A</bold>) hRad9 displays increased affinity to hMLH1 after MMS treatment. HeLa cells were mock-treated or treated with 0.005 and 0.01% MMS (g/solution volume) for 1 h, and the lysate was used for protein concentration controls (upper panel) and immunoprecipitation by anti-hMLH1 antibody (lower panel). (<bold>B</bold>) MNU treatment induced the interaction between hRad9 and hMLH1 in HeLa cells. HeLa cells were exposed to 0, 0.1 and 0.2 mM MNU in serum-free medium for 1 h. Immunoprecipitation and western blot analysis protocols were the same as in (A). Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. (<bold>C</bold>) The interaction between hRad9 and hMLH1 was significantly induced by MMS. Data were derived from three independent experiments as in (<bold>A</bold>). (<bold>D</bold>) The interaction between hRad9 and hMLH1 was significantly induced by MNU. The relative hRad9 levels were presented as mean &#177; SD from three independent experiments as described in (<bold>B</bold>). Asterisk indicates the statistical significance (<italic>P</italic> &lt; 0.01) between precipitated hRad9 levels from cells treated or untreated with MMS or MNU.</p>
###xml 1240 2445 1240 2443 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="51">Interaction between hRad9 and hMLH1 is enhanced in response to MMS or MNU treatment. (<bold>A</bold>) hRad9 displays increased affinity to hMLH1 after MMS treatment. HeLa cells were mock-treated or treated with 0.005 and 0.01% MMS (g/solution volume) for 1 h, and the lysate was used for protein concentration controls (upper panel) and immunoprecipitation by anti-hMLH1 antibody (lower panel). (<bold>B</bold>) MNU treatment induced the interaction between hRad9 and hMLH1 in HeLa cells. HeLa cells were exposed to 0, 0.1 and 0.2 mM MNU in serum-free medium for 1 h. Immunoprecipitation and western blot analysis protocols were the same as in (A). Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. (<bold>C</bold>) The interaction between hRad9 and hMLH1 was significantly induced by MMS. Data were derived from three independent experiments as in (<bold>A</bold>). (<bold>D</bold>) The interaction between hRad9 and hMLH1 was significantly induced by MNU. The relative hRad9 levels were presented as mean &#177; SD from three independent experiments as described in (<bold>B</bold>). Asterisk indicates the statistical significance (<italic>P</italic> &lt; 0.01) between precipitated hRad9 levels from cells treated or untreated with MMS or MNU.</p></caption>
###xml 2445 2445 2443 2443 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn686f5"/>
###xml 1231 2445 1231 2443 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="51">Interaction between hRad9 and hMLH1 is enhanced in response to MMS or MNU treatment. (<bold>A</bold>) hRad9 displays increased affinity to hMLH1 after MMS treatment. HeLa cells were mock-treated or treated with 0.005 and 0.01% MMS (g/solution volume) for 1 h, and the lysate was used for protein concentration controls (upper panel) and immunoprecipitation by anti-hMLH1 antibody (lower panel). (<bold>B</bold>) MNU treatment induced the interaction between hRad9 and hMLH1 in HeLa cells. HeLa cells were exposed to 0, 0.1 and 0.2 mM MNU in serum-free medium for 1 h. Immunoprecipitation and western blot analysis protocols were the same as in (A). Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. (<bold>C</bold>) The interaction between hRad9 and hMLH1 was significantly induced by MMS. Data were derived from three independent experiments as in (<bold>A</bold>). (<bold>D</bold>) The interaction between hRad9 and hMLH1 was significantly induced by MNU. The relative hRad9 levels were presented as mean &#177; SD from three independent experiments as described in (<bold>B</bold>). Asterisk indicates the statistical significance (<italic>P</italic> &lt; 0.01) between precipitated hRad9 levels from cells treated or untreated with MMS or MNU.</p></caption><graphic xlink:href="gkn686f5"/></fig>
N-nitroso-N-methylurea (MNU) is an SN1 DNA-alkylating agent which produces high levels of O6-methylguanine (O6-meG) on DNA in cells. The resulting O6-meG lesions are recognized and/or repaired by MMR proteins (49). Methyl methanesulfonate (MMS), a SN2 DNA-alkylating-agent, produces high levels of N7-methylguanine (N7-meG) and N3-methyladenine (N3-meA), which can lead to the formation of promutagenic abasic sites. MMR pathways also play a role in the repair of MMS-induced DNA lesions (50,51). To find out whether the activation of DNA MMR influences the interaction between hRad9 and hMLH1, we tested whether increases in cellular DNA lesions incurred by incubating HeLa cells with MNU and MMS would enhance hRad9-hMLH1 interactions. Indeed, the interaction between hRad9 and hMLH1 was enhanced by either MNU or MMS treatment (Figure 5). The protein loading control using 10% lysate indicates that hRad9 and hMLH1 did not change within the experimental period, and thus the higher amount of hRad9 copurified with hMLH1 was due to higher affinity in the presence of MMS or MNU. This enhancement of hMLH1-hRad9 interaction in response to MMS or MNU treatment implies that the hMLH1-hRad9 interaction is an important step in MMR. Figure 5.Interaction between hRad9 and hMLH1 is enhanced in response to MMS or MNU treatment. (A) hRad9 displays increased affinity to hMLH1 after MMS treatment. HeLa cells were mock-treated or treated with 0.005 and 0.01% MMS (g/solution volume) for 1 h, and the lysate was used for protein concentration controls (upper panel) and immunoprecipitation by anti-hMLH1 antibody (lower panel). (B) MNU treatment induced the interaction between hRad9 and hMLH1 in HeLa cells. HeLa cells were exposed to 0, 0.1 and 0.2 mM MNU in serum-free medium for 1 h. Immunoprecipitation and western blot analysis protocols were the same as in (A). Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. (C) The interaction between hRad9 and hMLH1 was significantly induced by MMS. Data were derived from three independent experiments as in (A). (D) The interaction between hRad9 and hMLH1 was significantly induced by MNU. The relative hRad9 levels were presented as mean +/- SD from three independent experiments as described in (B). Asterisk indicates the statistical significance (P < 0.01) between precipitated hRad9 levels from cells treated or untreated with MMS or MNU.
###end p 50
###begin p 51
###xml 86 87 86 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 383 384 383 384 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 733 734 733 734 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 870 871 870 871 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 875 876 875 876 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1060 1061 1058 1059 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1113 1114 1111 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Interaction between hRad9 and hMLH1 is enhanced in response to MMS or MNU treatment. (A) hRad9 displays increased affinity to hMLH1 after MMS treatment. HeLa cells were mock-treated or treated with 0.005 and 0.01% MMS (g/solution volume) for 1 h, and the lysate was used for protein concentration controls (upper panel) and immunoprecipitation by anti-hMLH1 antibody (lower panel). (B) MNU treatment induced the interaction between hRad9 and hMLH1 in HeLa cells. HeLa cells were exposed to 0, 0.1 and 0.2 mM MNU in serum-free medium for 1 h. Immunoprecipitation and western blot analysis protocols were the same as in (A). Ten percent of the lysate was used for the loading control and the remaining 90% for co-immunoprecipitation. (C) The interaction between hRad9 and hMLH1 was significantly induced by MMS. Data were derived from three independent experiments as in (A). (D) The interaction between hRad9 and hMLH1 was significantly induced by MNU. The relative hRad9 levels were presented as mean +/- SD from three independent experiments as described in (B). Asterisk indicates the statistical significance (P < 0.01) between precipitated hRad9 levels from cells treated or untreated with MMS or MNU.
###end p 51
###begin title 52
Rad9-deleted ES cells are defective in MMR
###end title 52
###begin p 53
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 479 485 479 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 819 827 819 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1011 1019 1011 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1055 1060 1055 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1085 1090 1085 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1090 1093 1090 1093 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1171 1176 1171 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1176 1179 1176 1179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1214 1219 1214 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1219 1222 1219 1222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1274 1279 1274 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1279 1282 1279 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1348 1353 1348 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1353 1356 1353 1356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1364 1372 1364 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1418 1423 1418 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1423 1426 1423 1426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1491 1496 1491 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1507 1515 1507 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1625 1634 1625 1634 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 1639 1642 1639 1642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1634 1642 1634 1642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9<sup>&#8211;/&#8211;</sup></italic>
###xml 1675 1676 1675 1676 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1848 1852 1848 1852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</italic>
###xml 2208 2213 2208 2213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 2489 2494 2489 2494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 2772 2773 2772 2773 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 3066 3072 3066 3072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 3074 3076 3074 3076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 3124 3125 3124 3125 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 3161 3164 3161 3164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 3171 3174 3171 3174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 3181 3184 3181 3184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 3156 3184 3156 3184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9<sup>+/+</sup>, mRad9<sup>&#8211;/&#8211;</sup>, mRad9<sup>&#8211;/&#8211;</sup></italic>
###xml 3187 3192 3187 3192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 3202 3205 3202 3205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 3197 3205 3197 3205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9<sup>&#8211;/&#8211;</sup></italic>
###xml 3208 3213 3208 3213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1634 3284 1634 3284 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="54"><italic>mRad9<sup>&#8211;/&#8211;</sup></italic> ES cells are deficient in MMR. (<bold>A</bold>) Experiments for detecting MMR activity. The reporter plasmid containing a T:G heteroduplex mismatch and a control plasmid containing homoduplex T:A in the start codon of <italic>EGFP</italic> were transfected into cells to measure MMR activity. MMR-mediated repair of T:G to T:A restored the starting codon and thus EGFP expression. Control plasmid containing intact mRFP-C1 sequence was co-transfected into the cells to monitor transfection efficiency. HCT116 cells were used as the MMR-negative control and HCT116 cells transfected with pZeoSV2-<italic>hMLH1</italic> as the positive control; only a small population of HCT116 cells transfected with the reporter plasmid containing the T:G heteroduplex appeared in the lower-right and upper-right regions (EGFP-positive) and a significant portion of the same cells co-transfected with pZeoSV2-<italic>hMLH1</italic> were located in the lower-right and upper-right regions. This MMR activity detection system was applied to monitor MMR activities of ES cells with and without Rad9. The cells containing Rad9 were significantly more efficient in repairing T:G into T:A than cells without Rad9. (<bold>B</bold>) Relative EGFP expressions of HCT116, HCT116+hMLH1 after co-transfection of nicked homo- or hetero-duplex EGFP plasmid and RFP plasmid (pmRFP-C1), derived from three independent experiments described in (A). The relative EGFP expression levels were calculated using a method developed by Lei <italic>et al.</italic> (<xref ref-type="bibr" rid="B32">32</xref>) and reflected MMR activities of these cells. (<bold>C</bold>) Relative EGFP expressions of <italic>mRad9<sup>+/+</sup>, mRad9<sup>&#8211;/&#8211;</sup>, mRad9<sup>&#8211;/&#8211;</sup></italic> + <italic>hRad9</italic> and <italic>mRad9<sup>&#8211;/&#8211;</sup></italic> + <italic>mRad9</italic> cells, derived from three independent experiments as described in (A).</p>
###xml 1634 3284 1634 3284 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="54"><italic>mRad9<sup>&#8211;/&#8211;</sup></italic> ES cells are deficient in MMR. (<bold>A</bold>) Experiments for detecting MMR activity. The reporter plasmid containing a T:G heteroduplex mismatch and a control plasmid containing homoduplex T:A in the start codon of <italic>EGFP</italic> were transfected into cells to measure MMR activity. MMR-mediated repair of T:G to T:A restored the starting codon and thus EGFP expression. Control plasmid containing intact mRFP-C1 sequence was co-transfected into the cells to monitor transfection efficiency. HCT116 cells were used as the MMR-negative control and HCT116 cells transfected with pZeoSV2-<italic>hMLH1</italic> as the positive control; only a small population of HCT116 cells transfected with the reporter plasmid containing the T:G heteroduplex appeared in the lower-right and upper-right regions (EGFP-positive) and a significant portion of the same cells co-transfected with pZeoSV2-<italic>hMLH1</italic> were located in the lower-right and upper-right regions. This MMR activity detection system was applied to monitor MMR activities of ES cells with and without Rad9. The cells containing Rad9 were significantly more efficient in repairing T:G into T:A than cells without Rad9. (<bold>B</bold>) Relative EGFP expressions of HCT116, HCT116+hMLH1 after co-transfection of nicked homo- or hetero-duplex EGFP plasmid and RFP plasmid (pmRFP-C1), derived from three independent experiments described in (A). The relative EGFP expression levels were calculated using a method developed by Lei <italic>et al.</italic> (<xref ref-type="bibr" rid="B32">32</xref>) and reflected MMR activities of these cells. (<bold>C</bold>) Relative EGFP expressions of <italic>mRad9<sup>+/+</sup>, mRad9<sup>&#8211;/&#8211;</sup>, mRad9<sup>&#8211;/&#8211;</sup></italic> + <italic>hRad9</italic> and <italic>mRad9<sup>&#8211;/&#8211;</sup></italic> + <italic>mRad9</italic> cells, derived from three independent experiments as described in (A).</p></caption>
###xml 3284 3284 3284 3284 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn686f6"/>
###xml 1625 3284 1625 3284 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="54"><italic>mRad9<sup>&#8211;/&#8211;</sup></italic> ES cells are deficient in MMR. (<bold>A</bold>) Experiments for detecting MMR activity. The reporter plasmid containing a T:G heteroduplex mismatch and a control plasmid containing homoduplex T:A in the start codon of <italic>EGFP</italic> were transfected into cells to measure MMR activity. MMR-mediated repair of T:G to T:A restored the starting codon and thus EGFP expression. Control plasmid containing intact mRFP-C1 sequence was co-transfected into the cells to monitor transfection efficiency. HCT116 cells were used as the MMR-negative control and HCT116 cells transfected with pZeoSV2-<italic>hMLH1</italic> as the positive control; only a small population of HCT116 cells transfected with the reporter plasmid containing the T:G heteroduplex appeared in the lower-right and upper-right regions (EGFP-positive) and a significant portion of the same cells co-transfected with pZeoSV2-<italic>hMLH1</italic> were located in the lower-right and upper-right regions. This MMR activity detection system was applied to monitor MMR activities of ES cells with and without Rad9. The cells containing Rad9 were significantly more efficient in repairing T:G into T:A than cells without Rad9. (<bold>B</bold>) Relative EGFP expressions of HCT116, HCT116+hMLH1 after co-transfection of nicked homo- or hetero-duplex EGFP plasmid and RFP plasmid (pmRFP-C1), derived from three independent experiments described in (A). The relative EGFP expression levels were calculated using a method developed by Lei <italic>et al.</italic> (<xref ref-type="bibr" rid="B32">32</xref>) and reflected MMR activities of these cells. (<bold>C</bold>) Relative EGFP expressions of <italic>mRad9<sup>+/+</sup>, mRad9<sup>&#8211;/&#8211;</sup>, mRad9<sup>&#8211;/&#8211;</sup></italic> + <italic>hRad9</italic> and <italic>mRad9<sup>&#8211;/&#8211;</sup></italic> + <italic>mRad9</italic> cells, derived from three independent experiments as described in (A).</p></caption><graphic xlink:href="gkn686f6"/></fig>
###xml 1069 1074 <span type="species:ncbi:10090">mouse</span>
###xml 1155 1160 <span type="species:ncbi:10090">mouse</span>
###xml 1404 1409 <span type="species:ncbi:9606">human</span>
To address the question of whether hRad9 acts together with MLH1 in MMR, an assay using a T:G mismatch-corrupted start codon in the EGFP gene transfected into tested cells was performed to quantitatively measure MMR activity in living cells (32). The T:G mismatch can be corrected to T:A by MMR, thus MMR activity can be determined by flow cytometry measuring the number of EGFP-positive cells and the intensity of EGFP expression (refer to 'Materials and methods' section). Lei et al. (32) reported that HCT116 cells did not express hMLH1 and did not repair the T:G mismatch efficiently, but transfection with hMLH1 into the cells compensated for the defect, leading to an increased number of EGFP-positive cells and enhanced intensity of EGFP expression. We were able to repeat this experiment as a positive control (Figure 6A and B). The MMR activity reflected by EGFP expression efficiency in FLAG-hMLH1-expressing HCT116 cells was 4.7 times that of parent HCT116 cells containing empty plasmid pFLAG-CMV2 (Figure 6B). Using this assay, we found that mRad9-deleted mouse ES cells (mRad9-/- cells) had a significantly lower MMR activity than wild-type mouse ES cells (mRad9+/+ cells), and ectopic expression in mRad9-/- ES cells of mRad9 at a level comparable to that in mRad9+/+ cells (data not shown) restored the MMR activity to the level of mRad9+/+ cells (Figure 6A and C). Ectopic expression of human Rad9 in mRad9-/- cells also complemented the loss of MMR activity resulting from mRad9 deletion (Figure 6A and C). Taken together, these data demonstrate that Rad9 plays an important role in MMR in mammalian cells. Figure 6.mRad9-/- ES cells are deficient in MMR. (A) Experiments for detecting MMR activity. The reporter plasmid containing a T:G heteroduplex mismatch and a control plasmid containing homoduplex T:A in the start codon of EGFP were transfected into cells to measure MMR activity. MMR-mediated repair of T:G to T:A restored the starting codon and thus EGFP expression. Control plasmid containing intact mRFP-C1 sequence was co-transfected into the cells to monitor transfection efficiency. HCT116 cells were used as the MMR-negative control and HCT116 cells transfected with pZeoSV2-hMLH1 as the positive control; only a small population of HCT116 cells transfected with the reporter plasmid containing the T:G heteroduplex appeared in the lower-right and upper-right regions (EGFP-positive) and a significant portion of the same cells co-transfected with pZeoSV2-hMLH1 were located in the lower-right and upper-right regions. This MMR activity detection system was applied to monitor MMR activities of ES cells with and without Rad9. The cells containing Rad9 were significantly more efficient in repairing T:G into T:A than cells without Rad9. (B) Relative EGFP expressions of HCT116, HCT116+hMLH1 after co-transfection of nicked homo- or hetero-duplex EGFP plasmid and RFP plasmid (pmRFP-C1), derived from three independent experiments described in (A). The relative EGFP expression levels were calculated using a method developed by Lei et al. (32) and reflected MMR activities of these cells. (C) Relative EGFP expressions of mRad9+/+, mRad9-/-, mRad9-/- + hRad9 and mRad9-/- + mRad9 cells, derived from three independent experiments as described in (A).
###end p 53
###begin p 54
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9<sup>&#8211;/&#8211;</sup></italic>
###xml 41 42 41 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</italic>
###xml 574 579 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 855 860 855 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
###xml 1138 1139 1138 1139 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1432 1438 1432 1438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1440 1442 1440 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1490 1491 1490 1491 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1527 1530 1527 1530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1537 1540 1537 1540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1547 1550 1547 1550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1522 1550 1522 1550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9<sup>+/+</sup>, mRad9<sup>&#8211;/&#8211;</sup>, mRad9<sup>&#8211;/&#8211;</sup></italic>
###xml 1553 1558 1553 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 1568 1571 1568 1571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1563 1571 1563 1571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9<sup>&#8211;/&#8211;</sup></italic>
###xml 1574 1579 1574 1579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
mRad9-/- ES cells are deficient in MMR. (A) Experiments for detecting MMR activity. The reporter plasmid containing a T:G heteroduplex mismatch and a control plasmid containing homoduplex T:A in the start codon of EGFP were transfected into cells to measure MMR activity. MMR-mediated repair of T:G to T:A restored the starting codon and thus EGFP expression. Control plasmid containing intact mRFP-C1 sequence was co-transfected into the cells to monitor transfection efficiency. HCT116 cells were used as the MMR-negative control and HCT116 cells transfected with pZeoSV2-hMLH1 as the positive control; only a small population of HCT116 cells transfected with the reporter plasmid containing the T:G heteroduplex appeared in the lower-right and upper-right regions (EGFP-positive) and a significant portion of the same cells co-transfected with pZeoSV2-hMLH1 were located in the lower-right and upper-right regions. This MMR activity detection system was applied to monitor MMR activities of ES cells with and without Rad9. The cells containing Rad9 were significantly more efficient in repairing T:G into T:A than cells without Rad9. (B) Relative EGFP expressions of HCT116, HCT116+hMLH1 after co-transfection of nicked homo- or hetero-duplex EGFP plasmid and RFP plasmid (pmRFP-C1), derived from three independent experiments described in (A). The relative EGFP expression levels were calculated using a method developed by Lei et al. (32) and reflected MMR activities of these cells. (C) Relative EGFP expressions of mRad9+/+, mRad9-/-, mRad9-/- + hRad9 and mRad9-/- + mRad9 cells, derived from three independent experiments as described in (A).
###end p 54
###begin title 55
The Ser160-mediated hRad9-hMLH1 interaction is important in MMR activity
###end title 55
###begin p 56
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9<sup>&#8211;/&#8211;</sup></italic>
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 272 275 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 353 356 353 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 348 356 348 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9<sup>&#8211;/&#8211;</sup></italic>
###xml 361 366 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 366 369 366 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 409 414 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 423 426 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 418 426 418 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9<sup>&#8211;/&#8211;</sup></italic>
###xml 502 511 502 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figures 6</xref>
###xml 517 525 517 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 556 561 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9</italic>
###xml 600 608 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 704 712 704 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 828 837 828 837 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7.</label>
###xml 922 927 922 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 927 930 927 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 933 941 933 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9-WT</italic>
###xml 996 1001 994 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1001 1004 999 1002 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1007 1018 1005 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9-S160A</italic>
###xml 1092 1097 1088 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1097 1100 1093 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 837 1255 837 1251 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="57">The Ser160 of hRad9 plays a significant role in MMR. The relative EGFP expression of <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> + <italic>hRad9-WT</italic> (0.786 &#177; 0.07) is significantly higher than that of <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> + <italic>hRad9-S160A</italic> (0.23 &#177; 0.022). Three hRad9-WT-expressing and 3 hRad9-S160A-expressing <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cell clones were tested for MMR activity, and similar results were obtained. In this figure, the result from one representative set of clones is given.</p>
###xml 837 1255 837 1251 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="57">The Ser160 of hRad9 plays a significant role in MMR. The relative EGFP expression of <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> + <italic>hRad9-WT</italic> (0.786 &#177; 0.07) is significantly higher than that of <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> + <italic>hRad9-S160A</italic> (0.23 &#177; 0.022). Three hRad9-WT-expressing and 3 hRad9-S160A-expressing <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cell clones were tested for MMR activity, and similar results were obtained. In this figure, the result from one representative set of clones is given.</p></caption>
###xml 1255 1255 1251 1251 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn686f7"/>
###xml 828 1255 828 1251 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F7" position="float"><label>Figure 7.</label><caption><p textid="57">The Ser160 of hRad9 plays a significant role in MMR. The relative EGFP expression of <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> + <italic>hRad9-WT</italic> (0.786 &#177; 0.07) is significantly higher than that of <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> + <italic>hRad9-S160A</italic> (0.23 &#177; 0.022). Three hRad9-WT-expressing and 3 hRad9-S160A-expressing <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cell clones were tested for MMR activity, and similar results were obtained. In this figure, the result from one representative set of clones is given.</p></caption><graphic xlink:href="gkn686f7"/></fig>
The functional significance of the interaction between hRad9 and hMLH1 was tested with the assay described above. We picked mRad9-/- cell clones that expressed wild type hRad9 (3 clones) and Ser160Ala hRad9 (3 clones) at levels close to the endogenous mRad9 level in mRad9+/+ cells (data not shown), and compared their MMR activities with those of mRad9-/- and mRad9+/+ cells. Ectopic expression of wild type hRad9 in mRad9-/- cells resulted in dramatically increased MMR activity as shown previously (Figures 6C and Figure 7), but expression of Ser160Ala hRad9 only increased MMR activity slightly (Figure 7). As shown previously, the Ser160Ala mutation severely demolished the hRad9-mMLH1 interaction (Figure 4). Taken together, these results suggest that hRad9 functions in the MMR pathway through its interaction with MLH1. Figure 7.The Ser160 of hRad9 plays a significant role in MMR. The relative EGFP expression of mRad9-/- + hRad9-WT (0.786 +/- 0.07) is significantly higher than that of mRad9-/- + hRad9-S160A (0.23 +/- 0.022). Three hRad9-WT-expressing and 3 hRad9-S160A-expressing mRad9-/- ES cell clones were tested for MMR activity, and similar results were obtained. In this figure, the result from one representative set of clones is given.
###end p 56
###begin p 57
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9-WT</italic>
###xml 159 164 157 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 164 167 162 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 170 181 168 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRad9-S160A</italic>
###xml 255 260 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 260 263 256 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
The Ser160 of hRad9 plays a significant role in MMR. The relative EGFP expression of mRad9-/- + hRad9-WT (0.786 +/- 0.07) is significantly higher than that of mRad9-/- + hRad9-S160A (0.23 +/- 0.022). Three hRad9-WT-expressing and 3 hRad9-S160A-expressing mRad9-/- ES cell clones were tested for MMR activity, and similar results were obtained. In this figure, the result from one representative set of clones is given.
###end p 57
###begin p 58
###xml 71 73 71 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N1</sub>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 135 140 135 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52 B53 B54 B55">52&#8211;55</xref>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 326 329 326 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 321 329 321 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9<sup>&#8211;/&#8211;</sup></italic>
###xml 373 376 373 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 368 376 368 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9<sup>+/+</sup></italic>
###xml 384 392 384 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 436 441 436 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52 B53 B54 B55">52&#8211;55</xref>
###xml 468 471 468 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 463 471 463 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9<sup>&#8211;/&#8211;</sup></italic>
###xml 515 518 515 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 511 518 511 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rad9<sup>+/+</sup></italic>
###xml 526 534 526 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 581 583 581 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N2</sub>
###xml 628 629 628 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 676 677 676 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 691 692 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 715 717 715 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N1</sub>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 737 738 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 752 753 752 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 815 817 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 895 904 895 904 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8.</label>
###xml 979 980 979 980 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1017 1022 1017 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1022 1025 1022 1025 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1036 1041 1036 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1041 1044 1041 1044 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1066 1071 1066 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1071 1074 1071 1074 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1229 1230 1228 1229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1629 1630 1628 1629 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1824 1829 1823 1828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1829 1832 1828 1831 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1926 1931 1925 1930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1931 1934 1930 1933 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 2070 2071 2069 2070 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2074 2075 2073 2074 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2202 2207 2201 2206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 2207 2210 2206 2209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 2242 2243 2241 2242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2358 2359 2357 2358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 2390 2395 2389 2394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 2395 2398 2394 2397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 2438 2439 2437 2438 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2469 2470 2468 2469 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 2630 2635 2629 2634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 2635 2638 2634 2637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 2652 2653 2651 2652 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 2947 2952 2946 2951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 2952 2955 2951 2954 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 3054 3055 3053 3054 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 3360 3361 3353 3354 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 904 3439 904 3432 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="59">The Ser160Ala mutation of hRad9 does not affect the known roles of hRad9. (<bold>A</bold>) Comparison of the sensitivities of <italic>mRad9</italic><sup>+/+</sup> ES cells, <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells and the two <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells that stably express hRad9-WT and hRad9-S160A, respectively. The four types of cells were treated with mock treatment, 250 &#956;M HU for 24 h, 10 J/m<sup>2</sup> and 6 Gy gamma rays, respectively, and then allowed to grow for 10 days to form cell colonies. The survival level stands for the ratio of the number of colonies formed from treated cells compared with the number of colonies formed from untreated cells. Results presented are the averages of three independent experiments, and each experimental data point is the average of duplicate cell samples. (<bold>B</bold>) The S/M checkpoint. The four types of cells described above were incubated in medium containing 1 mM HU for 0, 8 and 12 h, and then prepared for S/M checkpoint analysis by flow cytometry. The <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells stably expressing either hRad9-WT or hRad9-S160A showed intact S/M checkpoint while <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells containing the empty vector demonstrated prematured chromosome condensation (arrows) after incubation with HU for 8 or 12 h. (<bold>C</bold>) G<sub>2</sub>/M checkpoint. The four types of cells described above were irradiated with 10 Gy gamma rays and then grown for 0, 8 and 12 h. <italic>mRad9</italic><sup>+/+</sup> ES cells were arrested in the G<sub>2</sub>/M border 8 h after irradiation, and only a small population of the cells from the last cell cycle moved into the G<sub>1</sub> phase 12 h after irradiation. <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells were unable to arrest at the G<sub>2</sub>/M border and moved into the G<sub>1</sub> phase (arrow) 8 h after irradiation, and cells from the last cell cycle had already moved into the S phase (arrow) 12 h after irradiation. To confirm that the <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells in G<sub>1</sub> and S phases 8 and 12 h after irradiation were from the last cycle, 50 ng/ml colcemid was added to one set of cells to block cells in the M phase. Indeed, colcemid was able to block the cells in the M phase 8 and 12 h after irradiation, suggesting that they came from the last cell cycle. The <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells stably expressing either hRad9-WT or hRad9-S160A showed intact G2/M checkpoint control. (<bold>D</bold>) The different cell lines were incubated in serum-free medium containing various concentrations of MNU at 3&#176;C for 1 h. After rinsing, fresh medium was added to form colonies, and survival rates were determined. Results presented are the means of three separate experiments performed in duplicate. (<bold>E</bold>) The MMS-resistant experiment was carried out in the same way as that in (D).</p>
###xml 904 3439 904 3432 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="59">The Ser160Ala mutation of hRad9 does not affect the known roles of hRad9. (<bold>A</bold>) Comparison of the sensitivities of <italic>mRad9</italic><sup>+/+</sup> ES cells, <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells and the two <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells that stably express hRad9-WT and hRad9-S160A, respectively. The four types of cells were treated with mock treatment, 250 &#956;M HU for 24 h, 10 J/m<sup>2</sup> and 6 Gy gamma rays, respectively, and then allowed to grow for 10 days to form cell colonies. The survival level stands for the ratio of the number of colonies formed from treated cells compared with the number of colonies formed from untreated cells. Results presented are the averages of three independent experiments, and each experimental data point is the average of duplicate cell samples. (<bold>B</bold>) The S/M checkpoint. The four types of cells described above were incubated in medium containing 1 mM HU for 0, 8 and 12 h, and then prepared for S/M checkpoint analysis by flow cytometry. The <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells stably expressing either hRad9-WT or hRad9-S160A showed intact S/M checkpoint while <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells containing the empty vector demonstrated prematured chromosome condensation (arrows) after incubation with HU for 8 or 12 h. (<bold>C</bold>) G<sub>2</sub>/M checkpoint. The four types of cells described above were irradiated with 10 Gy gamma rays and then grown for 0, 8 and 12 h. <italic>mRad9</italic><sup>+/+</sup> ES cells were arrested in the G<sub>2</sub>/M border 8 h after irradiation, and only a small population of the cells from the last cell cycle moved into the G<sub>1</sub> phase 12 h after irradiation. <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells were unable to arrest at the G<sub>2</sub>/M border and moved into the G<sub>1</sub> phase (arrow) 8 h after irradiation, and cells from the last cell cycle had already moved into the S phase (arrow) 12 h after irradiation. To confirm that the <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells in G<sub>1</sub> and S phases 8 and 12 h after irradiation were from the last cycle, 50 ng/ml colcemid was added to one set of cells to block cells in the M phase. Indeed, colcemid was able to block the cells in the M phase 8 and 12 h after irradiation, suggesting that they came from the last cell cycle. The <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells stably expressing either hRad9-WT or hRad9-S160A showed intact G2/M checkpoint control. (<bold>D</bold>) The different cell lines were incubated in serum-free medium containing various concentrations of MNU at 3&#176;C for 1 h. After rinsing, fresh medium was added to form colonies, and survival rates were determined. Results presented are the means of three separate experiments performed in duplicate. (<bold>E</bold>) The MMS-resistant experiment was carried out in the same way as that in (D).</p></caption>
###xml 3439 3439 3432 3432 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn686f8"/>
###xml 895 3439 895 3432 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F8" position="float"><label>Figure 8.</label><caption><p textid="59">The Ser160Ala mutation of hRad9 does not affect the known roles of hRad9. (<bold>A</bold>) Comparison of the sensitivities of <italic>mRad9</italic><sup>+/+</sup> ES cells, <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells and the two <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells that stably express hRad9-WT and hRad9-S160A, respectively. The four types of cells were treated with mock treatment, 250 &#956;M HU for 24 h, 10 J/m<sup>2</sup> and 6 Gy gamma rays, respectively, and then allowed to grow for 10 days to form cell colonies. The survival level stands for the ratio of the number of colonies formed from treated cells compared with the number of colonies formed from untreated cells. Results presented are the averages of three independent experiments, and each experimental data point is the average of duplicate cell samples. (<bold>B</bold>) The S/M checkpoint. The four types of cells described above were incubated in medium containing 1 mM HU for 0, 8 and 12 h, and then prepared for S/M checkpoint analysis by flow cytometry. The <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells stably expressing either hRad9-WT or hRad9-S160A showed intact S/M checkpoint while <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells containing the empty vector demonstrated prematured chromosome condensation (arrows) after incubation with HU for 8 or 12 h. (<bold>C</bold>) G<sub>2</sub>/M checkpoint. The four types of cells described above were irradiated with 10 Gy gamma rays and then grown for 0, 8 and 12 h. <italic>mRad9</italic><sup>+/+</sup> ES cells were arrested in the G<sub>2</sub>/M border 8 h after irradiation, and only a small population of the cells from the last cell cycle moved into the G<sub>1</sub> phase 12 h after irradiation. <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells were unable to arrest at the G<sub>2</sub>/M border and moved into the G<sub>1</sub> phase (arrow) 8 h after irradiation, and cells from the last cell cycle had already moved into the S phase (arrow) 12 h after irradiation. To confirm that the <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells in G<sub>1</sub> and S phases 8 and 12 h after irradiation were from the last cycle, 50 ng/ml colcemid was added to one set of cells to block cells in the M phase. Indeed, colcemid was able to block the cells in the M phase 8 and 12 h after irradiation, suggesting that they came from the last cell cycle. The <italic>mRad9</italic><sup>&#8211;/&#8211;</sup> ES cells stably expressing either hRad9-WT or hRad9-S160A showed intact G2/M checkpoint control. (<bold>D</bold>) The different cell lines were incubated in serum-free medium containing various concentrations of MNU at 3&#176;C for 1 h. After rinsing, fresh medium was added to form colonies, and survival rates were determined. Results presented are the means of three separate experiments performed in duplicate. (<bold>E</bold>) The MMS-resistant experiment was carried out in the same way as that in (D).</p></caption><graphic xlink:href="gkn686f8"/></fig>
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
It has been reported that cells deficient in MMR are more tolerant to SN1 type DNA methylation agents than their parental cells (18,19,52-55). To investigate whether mRad9-deleted mouse ES cells are resistant to such DNA methylators or not, the ES cells mentioned above were examined for sensitivity to MNU. As expected, mRad9-/- cells were more resistant to MNU than mRad9+/+ cells (Figure 8D), consistent with previous studies (18,19,52-55). On the other hand, mRad9-/- cells were more sensitive to MMS than mRad9+/+ cells (Figure 8E), this may be due to the fact that MMS is a SN2 type methylating agent producing far fewer O6mG adducts (0.3%) and a greater proportion of N3mA (10%) and N7mG adducts (87%) than SN1 families (56,57). N3mA (10%) and N7mG adducts are repaired through base-excision repair pathway (55), so the damage induced by MMS is repaired mainly by BER rather than by MMR. Figure 8.The Ser160Ala mutation of hRad9 does not affect the known roles of hRad9. (A) Comparison of the sensitivities of mRad9+/+ ES cells, mRad9-/- ES cells and the two mRad9-/- ES cells that stably express hRad9-WT and hRad9-S160A, respectively. The four types of cells were treated with mock treatment, 250 muM HU for 24 h, 10 J/m2 and 6 Gy gamma rays, respectively, and then allowed to grow for 10 days to form cell colonies. The survival level stands for the ratio of the number of colonies formed from treated cells compared with the number of colonies formed from untreated cells. Results presented are the averages of three independent experiments, and each experimental data point is the average of duplicate cell samples. (B) The S/M checkpoint. The four types of cells described above were incubated in medium containing 1 mM HU for 0, 8 and 12 h, and then prepared for S/M checkpoint analysis by flow cytometry. The mRad9-/- ES cells stably expressing either hRad9-WT or hRad9-S160A showed intact S/M checkpoint while mRad9-/- ES cells containing the empty vector demonstrated prematured chromosome condensation (arrows) after incubation with HU for 8 or 12 h. (C) G2/M checkpoint. The four types of cells described above were irradiated with 10 Gy gamma rays and then grown for 0, 8 and 12 h. mRad9+/+ ES cells were arrested in the G2/M border 8 h after irradiation, and only a small population of the cells from the last cell cycle moved into the G1 phase 12 h after irradiation. mRad9-/- ES cells were unable to arrest at the G2/M border and moved into the G1 phase (arrow) 8 h after irradiation, and cells from the last cell cycle had already moved into the S phase (arrow) 12 h after irradiation. To confirm that the mRad9-/- ES cells in G1 and S phases 8 and 12 h after irradiation were from the last cycle, 50 ng/ml colcemid was added to one set of cells to block cells in the M phase. Indeed, colcemid was able to block the cells in the M phase 8 and 12 h after irradiation, suggesting that they came from the last cell cycle. The mRad9-/- ES cells stably expressing either hRad9-WT or hRad9-S160A showed intact G2/M checkpoint control. (D) The different cell lines were incubated in serum-free medium containing various concentrations of MNU at 3degreesC for 1 h. After rinsing, fresh medium was added to form colonies, and survival rates were determined. Results presented are the means of three separate experiments performed in duplicate. (E) The MMS-resistant experiment was carried out in the same way as that in (D).
###end p 58
###begin p 59
###xml 75 76 75 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 167 170 167 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 325 326 324 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 725 726 724 725 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 920 925 919 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 925 928 924 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1022 1027 1021 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1027 1030 1026 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1166 1167 1165 1166 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1170 1171 1169 1170 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1298 1303 1297 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1303 1306 1302 1305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1338 1339 1337 1338 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1454 1455 1453 1454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1486 1491 1485 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1491 1494 1490 1493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1534 1535 1533 1534 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1565 1566 1564 1565 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1726 1731 1725 1730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 1731 1734 1730 1733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 1748 1749 1747 1748 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 2043 2048 2042 2047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 2048 2051 2047 2050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 2150 2151 2149 2150 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2456 2457 2449 2450 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
The Ser160Ala mutation of hRad9 does not affect the known roles of hRad9. (A) Comparison of the sensitivities of mRad9+/+ ES cells, mRad9-/- ES cells and the two mRad9-/- ES cells that stably express hRad9-WT and hRad9-S160A, respectively. The four types of cells were treated with mock treatment, 250 muM HU for 24 h, 10 J/m2 and 6 Gy gamma rays, respectively, and then allowed to grow for 10 days to form cell colonies. The survival level stands for the ratio of the number of colonies formed from treated cells compared with the number of colonies formed from untreated cells. Results presented are the averages of three independent experiments, and each experimental data point is the average of duplicate cell samples. (B) The S/M checkpoint. The four types of cells described above were incubated in medium containing 1 mM HU for 0, 8 and 12 h, and then prepared for S/M checkpoint analysis by flow cytometry. The mRad9-/- ES cells stably expressing either hRad9-WT or hRad9-S160A showed intact S/M checkpoint while mRad9-/- ES cells containing the empty vector demonstrated prematured chromosome condensation (arrows) after incubation with HU for 8 or 12 h. (C) G2/M checkpoint. The four types of cells described above were irradiated with 10 Gy gamma rays and then grown for 0, 8 and 12 h. mRad9+/+ ES cells were arrested in the G2/M border 8 h after irradiation, and only a small population of the cells from the last cell cycle moved into the G1 phase 12 h after irradiation. mRad9-/- ES cells were unable to arrest at the G2/M border and moved into the G1 phase (arrow) 8 h after irradiation, and cells from the last cell cycle had already moved into the S phase (arrow) 12 h after irradiation. To confirm that the mRad9-/- ES cells in G1 and S phases 8 and 12 h after irradiation were from the last cycle, 50 ng/ml colcemid was added to one set of cells to block cells in the M phase. Indeed, colcemid was able to block the cells in the M phase 8 and 12 h after irradiation, suggesting that they came from the last cell cycle. The mRad9-/- ES cells stably expressing either hRad9-WT or hRad9-S160A showed intact G2/M checkpoint control. (D) The different cell lines were incubated in serum-free medium containing various concentrations of MNU at 3degreesC for 1 h. After rinsing, fresh medium was added to form colonies, and survival rates were determined. Results presented are the means of three separate experiments performed in duplicate. (E) The MMS-resistant experiment was carried out in the same way as that in (D).
###end p 59
###begin p 60
###xml 248 249 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 338 346 338 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 370 371 370 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 397 405 397 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
In order to confirm whether the S160A mutation of hRad9 specifically influences MMR function, we tested the effect of the S160A mutation on the known functions of hRad9, such as sensitivity to HU, 254-nm UV light and gamma rays as well as S/M and G2/M checkpoint controls. This mutation did not sensitize ES cells to DNA-damaging agents (Figure 8A), nor lead to S/M or G2/M checkpoint deficiency (Figure 8B and C), suggesting that the overall structural integrity of hRad9 is not affected by the S160A mutation, and that hRad9 plays a role in MMR specifically via the hRad9-hMLH1 interaction.
###end p 60
###begin title 61
DISCUSSION
###end title 61
###begin p 62
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 192 201 192 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures 1</xref>
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 257 266 257 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figures 4</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 274 275 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
hRad9 is critical for cell cycle checkpoint control (17,58) and for HR repair (40) and base-pair excision repair (35,38). In this study we have shown that hRad9 directly interacts with hMLH1 (Figures 1 and 2), and this interaction is important for DNA MMR (Figures 4, 6 and 7). Recent studies have shown that mismatch proteins function as sensors for cell cycle checkpoint controls. Mismatch protein MSH2 (MutS homolog 2) can interact with ATR, and MutSalpha and MutLalpha are required to activate ATR to phosphorylate Chk1 and promote cell cycle checkpoint control in response to MNNG-caused DNA methylation damage (59,60). This study shows that Rad9 plays an important role in MMR via a direct interaction with MMR protein MLH1. Whether there is a signaling flow from cell cycle checkpoint via checkpoint protein Rad9 toward mismatch repair is currently unclear.
###end p 62
###begin p 63
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6 B7 B8 B9 B10 B11">6&#8211;11</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 387 395 387 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
The current prevailing view is that hRad9, hRad1 and hHus1 form a PCNA-like ring structure, the 9-1-1 complex (6-11), and in this heterotrimer form function in cell cycle checkpoint control and DNA repair (61,62). PCNA itself can also interact with hMLH1 and play a role in 3' to 5' excision in MMR (22). However, unlike either hRad 1 or hHus1, hRad9 is able to immunoprecipitate hMLH1 (Figure 3). This implies that hRad9's function in MMR is not in the 9-1-1 complex form. A hRad9 mutant that contains point mutations that affect interactions with hHus1 and/or hRad1 would be useful to further clarify if hRad9 plays a role in MMS independent of the 9-1-1 complex.
###end p 63
###begin p 64
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 202 218 202 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 371 375 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ExoI</italic>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 202 218 <span type="species:ncbi:562">Escherichia coli</span>
###xml 402 407 <span type="species:ncbi:4932">yeast</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
hRad9 has been reported to possess 3' to 5' nuclease activity (63) and this feature of hRad9 is compatible with its role in MMR. Four redundant exonucleases (I, VII, X and RecJ) have been identified in Escherichia coli MMR (19), whereas only ExoI has been experimentally implicated as an MMR-associated 5'-directed exonuclease in eukaryotic cells (26,64). The effects of ExoI deficiency on MMR in both yeast and mice are moderate compared to those of Msh2 or Mlh1, and this suggests the existence of more functionally redundant exonucleases in these organisms (26,64). Recent studies have shown that regulatory factor X (RFX) and MRE11 play roles in MMR. RFX stimulates mismatch-dependent 5' to 3' excision activity (27), and MRE11 possesses mismatch-dependent 3' to 5' excision activity (65). Since hRad9 has 3' to 5' nuclease activity (63), hRad9 is likely to also function in mismatch-dependent 3' to 5' excision. However, the 3' to 5' nuclease activity of hRad9 is weaker than would be expected if hRad9's 3' to 5' nuclease activity is important in MMR. We cannot exclude the possibility that hRad9 may function in MMR through the other unknown ways. Nevertheless, this hypothesis that hRad9 plays a role in MMR-dependent 3' to 5' nuclease activity merits future experimental studies.
###end p 64
###begin p 65
###xml 187 192 187 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66 B67 B68 B69">66&#8211;69</xref>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B70">70</xref>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRad9</italic>
###xml 664 673 664 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figures 4</xref>
###xml 678 679 678 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 195 199 <span type="species:ncbi:10090">Mice</span>
###xml 340 345 <span type="species:ncbi:10090">mouse</span>
The Rad9-MLH1 interaction might be a hot spot for mutation in tumor cells. The hMLH1 mutation leads to hereditary nonpolyposis colorectal cancer (HNPCC) and various other types of tumor (66-69). Mice with an mRad9 deletion in skin keratinocytes are susceptible to developing skin tumors (70). The deletion of mRad9 in all cell types causes mouse embryonic lethality, possibly due to the loss of its many important functions including cell cycle checkpoint control, base-excision repair and DNA double-strand break repair. In this study, we have shown that the Ser160Ala mutation of hRad9 leads to drastic reduction of the hRad9-hMLH1 interaction and MMR activity (Figures 4 and 6), but has no impact on cell cycle checkpoint control and cellular sensitivity to gamma rays, UV-light and DNA replication inhibitorHU. Cells with this type of mutation may easily survive and possess a mutator phenotype, thus developing into tumors.
###end p 65
###begin title 66
FUNDING
###end title 66
###begin p 67
National Natural Science Foundation of China (30530180); National Protein Project of Ministry of Science and Technology (2006CB910 902); and Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R63). National Key Basic Research Program of China (973) of Ministry of Science and Technology (2004CB720004). Funding for open access charges: National Natural Science Foundation of China (30530180).
###end p 67
###begin p 68
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 68
###begin title 69
ACKNOWLEDGEMENTS
###end title 69
###begin p 70
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1</italic>
We thank Dr Liusheng He for providing pmRFP-C1 plasmid and Dr Lene Juel Rasmussen for the kind gift of the plasmid of pEGFP-hMLH1.
###end p 70
###begin title 71
REFERENCES
###end title 71
###begin article-title 72
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints
###end article-title 72
###begin article-title 73
Checkpoints: controls that ensure the order of cell cycle events
###end article-title 73
###begin article-title 74
###xml 66 79 <span type="species:ncbi:4932">S. cerevisiae</span>
A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage
###end article-title 74
###begin article-title 75
Structure-based predictions of Rad1, Rad9, Hus1 and Rad17 participation in sliding clamp and clamp-loading complexes
###end article-title 75
###begin article-title 76
###xml 37 42 <span type="species:ncbi:9606">human</span>
Purification and characterization of human DNA damage checkpoint Rad complexes
###end article-title 76
###begin article-title 77
Genotoxin-induced Rad9-Hus1-Rad1 (9-1-1) chromatin association is an early checkpoint signaling event
###end article-title 77
###begin article-title 78
###xml 18 23 <span type="species:ncbi:9606">human</span>
Structures of the human Rad17-replication factor C and checkpoint Rad 9-1-1 complexes visualized by glycerol spray/low voltage microscopy
###end article-title 78
###begin article-title 79
###xml 41 46 <span type="species:ncbi:9606">human</span>
Clamp and clamp loader structures of the human checkpoint protein complexes, Rad9-1-1 and Rad17-RFC
###end article-title 79
###begin article-title 80
Biochemical characterization of DNA damage checkpoint complexes: clamp loader and clamp complexes with specificity for 5' recessed DNA
###end article-title 80
###begin article-title 81
###xml 90 115 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
Cloning and analysis of a gene involved in DNA repair and recombination, the rad1 gene of Schizosaccharomyces pombe
###end article-title 81
###begin article-title 82
###xml 62 87 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
Cloning and characterisation of the rad9 DNA repair gene from Schizosaccharomyces pombe
###end article-title 82
###begin article-title 83
###xml 34 59 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
Molecular cloning and analysis of Schizosaccharomyces pombe rad9, a gene involved in DNA repair and mutagenesis
###end article-title 83
###begin article-title 84
###xml 0 13 <span type="species:ncbi:4896">Fission yeast</span>
Fission yeast genes involved in coupling mitosis to completion of DNA replication
###end article-title 84
###begin article-title 85
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Inactivation of mouse Hus1 results in genomic instability and impaired responses to genotoxic stress
###end article-title 85
###begin article-title 86
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
Deletion of mouse rad9 causes abnormal cellular responses to DNA damage, genomic instability, and embryonic lethality
###end article-title 86
###begin article-title 87
DNA mismatch repair
###end article-title 87
###begin article-title 88
DNA mismatch repair: functions and mechanisms
###end article-title 88
###begin article-title 89
Mechanisms in eukaryotic mismatch repair
###end article-title 89
###begin article-title 90
Mechanisms and functions of DNA mismatch repair
###end article-title 90
###begin article-title 91
###xml 10 15 <span type="species:ncbi:9606">human</span>
A defined human system that supports bidirectional mismatch-provoked excision
###end article-title 91
###begin article-title 92
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human mismatch repair: reconstitution of a nick-directed bidirectional reaction
###end article-title 92
###begin article-title 93
###xml 30 35 <span type="species:ncbi:9606">human</span>
Reconstitution of 5'-directed human mismatch repair in a purified system
###end article-title 93
###begin article-title 94
exo1-Dependent mutator mutations: model system for studying functional interactions in mismatch repair
###end article-title 94
###begin article-title 95
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility
###end article-title 95
###begin article-title 96
Identification of regulatory factor X as a novel mismatch repair stimulatory factor
###end article-title 96
###begin article-title 97
hMRE11 deficiency leads to microsatellite instability and defective DNA mismatch repair
###end article-title 97
###begin article-title 98
###xml 37 42 <span type="species:ncbi:9606">human</span>
Mechanism of 5'-directed excision in human mismatch repair
###end article-title 98
###begin article-title 99
###xml 28 33 <span type="species:ncbi:9606">human</span>
Physical interactions among human checkpoint control proteins HUS1p, RAD1p, and RAD9p, and implications for the regulation of cell cycle progression
###end article-title 99
###begin article-title 100
###xml 52 57 <span type="species:ncbi:9606">human</span>
Identification and characterization of a paralog of human cell cycle checkpoint gene HUS1
###end article-title 100
###begin article-title 101
Measurement of DNA mismatch repair activity in live cells
###end article-title 101
###begin article-title 102
Analysis of the mammalian cell cycle by flow cytometry
###end article-title 102
###begin article-title 103
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human Rad9 checkpoint protein stimulates the carbamoyl phosphate synthetase activity of the multifunctional protein CAD
###end article-title 103
###begin article-title 104
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates DNA repair enzyme TDG glycosylase
###end article-title 104
###begin article-title 105
The checkpoint clamp, Rad9-Rad1-Hus1 complex, preferentially stimulates the activity of apurinic/apyrimidinic endonuclease 1 and DNA polymerase beta in long patch base excision repair
###end article-title 105
###begin article-title 106
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human checkpoint sensor Rad9-Rad1-Hus1 interacts with and stimulates NEIL1 glycosylase
###end article-title 106
###begin article-title 107
Physical and functional interactions between MutY glycosylase homologue (MYH) and checkpoint proteins Rad9-Rad1-Hus1
###end article-title 107
###begin article-title 108
###xml 103 116 <span type="species:ncbi:4896">fission yeast</span>
###xml 118 143 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
Interaction of checkpoint proteins Hus1/Rad1/Rad9 with DNA base excision repair enzyme MutY homolog in fission yeast, Schizosaccharomyces pombe
###end article-title 108
###begin article-title 109
Mammalian Rad9 plays a role in telomere stability, S- and G2-phase-specific cell survival, and homologous recombinational repair
###end article-title 109
###begin article-title 110
Physical and functional interactions between nucleotide excision repair and DNA damage checkpoint
###end article-title 110
###begin article-title 111
Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group A by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation
###end article-title 111
###begin article-title 112
###xml 28 33 <span type="species:ncbi:9606">human</span>
Mechanism of stimulation of human DNA ligase I by the Rad9-rad1-Hus1 checkpoint complex
###end article-title 112
###begin article-title 113
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human checkpoint sensor and alternative DNA clamp Rad9-Rad1-Hus1 modulates the activity of DNA ligase I, a component of the long-patch base excision repair machinery
###end article-title 113
###begin article-title 114
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human Rad9/Rad1/Hus1 damage sensor clamp interacts with DNA polymerase beta and increases its DNA substrate utilisation efficiency: implications for DNA repair
###end article-title 114
###begin article-title 115
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human G2 checkpoint control protein hRAD9 is a nuclear phosphoprotein that forms complexes with hRAD1 and hHUS1
###end article-title 115
###begin article-title 116
Reconstitution and molecular analysis of the hRad9-hHus1-hRad1 (9-1-1) DNA damage responsive checkpoint complex
###end article-title 116
###begin article-title 117
###xml 15 20 <span type="species:ncbi:9606">human</span>
Loading of the human 9-1-1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro
###end article-title 117
###begin article-title 118
Self-destruction and tolerance in resistance of mammalian cells to alkylation damage
###end article-title 118
###begin article-title 119
Two pathways for base excision repair in mammalian cells
###end article-title 119
###begin article-title 120
Impairment of proliferating cell nuclear antigen-dependent apurinic/apyrimidinic site repair on linear DNA
###end article-title 120
###begin article-title 121
###xml 87 92 <span type="species:ncbi:9606">human</span>
N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells
###end article-title 121
###begin article-title 122
The multifaceted mismatch-repair system
###end article-title 122
###begin article-title 123
Mechanisms of tolerance to DNA damaging therapeutic drugs
###end article-title 123
###begin article-title 124
Mismatch repair and DNA damage signalling
###end article-title 124
###begin article-title 125
Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents
###end article-title 125
###begin article-title 126
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
###end article-title 126
###begin article-title 127
Phosphorylation sites on Tyr28 and the C-terminus of Rad9 are required for inhibition of premature chromosomal condensation across the entire s phase
###end article-title 127
###begin article-title 128
ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts
###end article-title 128
###begin article-title 129
MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation
###end article-title 129
###begin article-title 130
The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1
###end article-title 130
###begin article-title 131
Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex
###end article-title 131
###begin article-title 132
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human DNA damage checkpoint protein hRAD9 is a 3' to 5' exonuclease
###end article-title 132
###begin article-title 133
###xml 39 63 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Identification and characterization of Saccharomyces cerevisiae EXO1, a gene encoding an exonuclease that interacts with MSH2
###end article-title 133
###begin article-title 134
The interplay between hMLH1 and hMRE11: role in MMR and the effect of hMLH1 mutations
###end article-title 134
###begin article-title 135
Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1
###end article-title 135
###begin article-title 136
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing
###end article-title 136
###begin article-title 137
Distinct effects of the recurrent Mlh1G67R mutation on MMR functions, cancer, and meiosis
###end article-title 137
###begin article-title 138
Mutations associated with HNPCC predisposition - Update of ICG-HNPCC/INSiGHT mutation database
###end article-title 138
###begin article-title 139
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Targeted deletion of Rad9 in mouse skin keratinocytes enhances genotoxin-induced tumor development
###end article-title 139

